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RESUMO	  
 
Introdução: A hipertensão arterial é a principal causa de mortalidade na 
população em geral. Ela é um importante fator de risco para doença vascular 
cerebral, principal causa de morte de um adulto e de incapacitância  em muitos 
países desenvolvidos. A sua prevalência  é estimada em cerca de um bilião de 
pessoas e  pode estar relacionada com até 7 milhões de morte por ano. Em 
Portugal estima-se que cerca de 42% da população adulta (três milhões) de 
pessoas sejam hipertensos. Muitos deles não conhecem a sua situação e apenas 
11% destes são tratados adequadamente. A prevalência de hipertensão aumenta 
com a idade e atinge cerca de 78% entre as pessoas com mais de 64 anos, o que 
motiva um maior número de consultas médicas, gerando altos custos para o 
sistema nacional de saúde. Segundo a literatura, o primeiro ano de tratamento 
40% irão abandonar a terapia e após 5-10 anos até 60% irão interromper o uso da 
sua prescrição para hipertensão. O uso da acupuntura poderá ajudar a superar 
estas dificuldades ao diminuir ou substituir a quantidade de droga necessária e 
também porque as visitas frequentes à clínica melhoram a aderência ao 
tratamento (medicamentos e/ou mudanças no estilo de vida). 
 
Objetivo: Estudar o efeito agudo da acupuntura nos pacientes com hipertensão 
arterial essencial utilizando o monitoramento de pressão arterial de 24 horas. 
(MAPA). 
 
Métodos: Um protocolo clínico preliminar,  prospectivo, randomizado, 
controlado, duplo-cego. Pacientes com idade inferior a 70 anos, com hipertensão 
essencial classificada com normal alta, grau1 ou grau 2 de acordo com as 
recomendações da ESH/ESC serão avaliados com um MAPA inicial (basal) e a 
análise do risco cardiovascular será realizada. Eles serão então randomizados 
para acupuntura ‘verdadeira’ ou acupuntura sham- a acupuntura verdadeira será 
os pontos selecionados como úteis no contexto da medicina tradicional chinesa, 
no caso deste estudo: F39, Pc 6, Rg14, F20, Rs12, L6, R7  e acupunctura sham  
aqueles pontos considerados sem ação para hipertensão orientada por artigo 
previamente publicado. Os pacientes serão submetidos a 3 sessões ( Terça, 
quarta e quinta) de terapia  acupuntura  (verdadeira ou sham). A tensão arterial e 
a frequência cardíaca serão mensuradas de acordo com os critérios da ESH/ESC 
antes e após cada intervenção. Um outro MAPA será realizado após o término das 
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3 sessões. O principal parâmetro será a média das pressões arteriais sistólica e 
diastólica. Paramêtros secundários serão as médias das tensões arteriais sistólica 
e diastólica durante o dia e durante a noite, e também a variabilidade das tensões 
arteriais (standard deviation em torno do valor médio). 
 
Resultados: Dois grandes contribuintes para a hipertensão arterial são o sistema 
renina-angiotensina-aldosterona e a ativação crónica do sistema nervoso 
simpático. Alguns estudos experimentais recentes relataram que a acupuntura 
reduz a atividade neural no rVLM, com isso reduzindo a atividade simpática. Há 
também trabalhos dizendo que a acupuntura pode reduzir os níveis plasmáticos 
de renina-angiotensina-aldosterona. Deste modo, este estudo pode revelar um 
decréscimo significantivo nos níveis de tensão arterial. Também como um 
parâmetro secundário, a variabilidade da tensão arterial pode ter um valor 
prognóstico no tratamento da hipertensão , ao analisar este parâmetro 
poderemos avaliar também, indiretamente,  o efeito da acupuntura na piora das 
lesões de órgão alvo da hipertensão e incidência de eventos cardiovasculares. 
 
Discussão: Resultados deste estudo podem auxiliar um maior estudo , 
prospectivo, randomizado, multi-cego, com follow up mais prolongados e indicar 
a possibilidade de termos uma outra ferramenta interessante para tratar esta 
doença que é responsável por um grande número de incapacitados e também 
mortes ao redor do mundo. 
 
Palavras-chave: Hipertensão, acupuntura, medicina tradicional chinesa 
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ABSTRACT: 
Introduction: Hypertension is the first cause of death worldwide. It is also an 
important risk factor for cerebral vascular disease, main cause of adult death and 
disability in many developed countries. Hypertension prevalence in the world is 
estimated to be almost 1 billion individuals and it can be related to as much as 
7million deaths per year. It is estimated that in Portugal about 42%  of the adult 
population(3million people) have hypertension. Many of them unaware of their 
condition, and only about 11% are treated adequately. The prevalence of 
hypertension increases with the age of the people, reaching about 78% among 
older than 64 years and motivates more clinical consultation, generating high 
costs to the National Health System. According to the literature, in the first year 
of therapy 40% will abandon the treatment and after 5-10 years as much as 60% 
will interrupt their prescription for hypertension. The use of acupuncture could 
help overcome these difficulties, by either diminishing or substituting the amount 
of drug required, and also because frequent visits to the clinic eases the 
compliance to the treatment (drugs and/or adjustment of lifestyle).  
 
Objective: Study the acute effect of the acupuncture in patients with essential 
hypertension using 24 –Ambulatory Blood pressure monitor results. 
Methods: A clinical protocol of preliminary, prospective, randomized, controlled, 
double-blinded clinical trial design. Patients aged < 70 years, with essential 
hypertension classified as high normal, grade1 or grade 2 hypertensive patients 
according to ESH/ESC 2007 guidelines will be evaluated with an initial (baseline) 
24-ABPM and assessment of cardiovascular risk will be made. Then they will be 
randomized to either ‘real’ acupuncture or sham acupuncture. –‘real’ 
acupuncture being points selected as useful in the context of Chinese medicine-in 
this study F39, Pc 6, Rg14, F20, Rs12, L6, R7 and sham acupuncture those points 
considered inactive for hypertension, oriented by previous published trial. The 
patients  will be submitted to 3 sessions (Tue.Wed,Thur) of acupuncture 
treatment (real or sham). BP and heart rate will be measured according to 
ESH/ESC criteria before and after each intervention. Another 24-ABPM will be 
made after the completion of the 3 sessions. Main parameter will be the average 
systolic and diastolic blood pressure. Secondary parameters will be average 
daytime and nighttimes systolic and diastolic blood pressure, and also the blood 
pressure variability (standard deviation around mean values).The acute effect of 
the blinded acupuncture will be done on the first day of treatment. 
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Results:  Acupuncture exerts sympatholytic, pro-vagotonic, and action on the 
renin, angiotensin aldosterone system effects according to recent literature. It 
was discovered a specific neurological pathway participating in acupuncture 
inhibition of excitatory cardiovascular reflexes at the rostral ventrolateral medulla 
cardiovascular center . All of which acts in the pathophysiology of the 
hypertension .The study may reveal a significant decrease in both systolic and 
diastolic blood pressure, compared to the sham group. By analysing the 24-ABPM 
data we could get more accurate, reproducible  measurement of the extent of the 
reduction induced by the treatment, in addition, it can provide information 
regarding to in which part of the 24 hours (day or night) the results were more 
pronounced.  
Discussion: Results from this study may in the future grant a larger prospective, 
controlled, multi-blinded, randomized protocols, with longer follow up periods, to 
have another interesting tool to treat this awful disease, responsible for a great 
number of  disabilities and deaths worldwide. 
 
Key words: Hypertension; acupuncture; traditional Chinese medicine  
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1.	  INTRODUCTION	  
 
1.1Epidemiology	  
 
Hypertension is the first cause of death worldwide not only due to its high 
prevalence among the population but also because it is the major risk factor for 
many cardiovascular and related diseases, and can also lead to other diseases 
that increase the cardiovascular risk as well. (Ezzati, Lopez, Rodgers, Vander 
Hoorn, Murray, & Group., 2002)(Kearney, Whelton, Reynolds, Muntner, Whelton, & 
He, 2005)(Martiniuk AL, 2007) As such it is also an important risk factor for 
cerebral vascular disease, main cause of adult death and disability in many 
developed countries.(Flachskampf, et al., 2007). Hypertension is also associated 
with an increase in the risk of dementia.(Skoog, et al., 1996) 
Hypertension prevalence worldwide is estimated to be almost 1 billion 
individuals and it can be related to as much as 7million deaths per year.(WHO, 
2002) 
It is also estimated that in Portugal around 42% of the adult population 
aged 18-90 years has hypertension. That number corresponds to approximately 3 
million people. Among those patients only 36% are aware of their high blood 
pressure and only about 11% are treated adequately. The prevalence of 
hypertension increases with the age of the people, reaching about 78% among 
older than 64 years(Macedo, Lima, Silva, Alcantara, Ramalhinho, & Carmona, 
2005), and motivates more clinical consultation, generating higher costs to the 
national health system.(Zurro & Pérez, 2008) 
There are some racial differences in the incidence of hypertension, both 
environmental and genetic factors may contribute to this factor. Migrants tend to 
develop the rates of hypertension similar to the new resident zone and studies 
with before the age of 55 high blood pressure occurs almost 4 times more 
frequently among those with family history of high blood pressure (BP). But for 
most individuals the hypertension is probably a multigenic disorder and the 
environment seems to play a big role in its development. Essential hypertension 
is a polygenic thus different patients may carry different phenotypes (obesity, 
dyslipidaemia, insulin resistance) depending on the different subset of genes 
involved  (Fauci, et al., 2008)  
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Among the environmental factors are obesity and weight gain, dietary 
sodium intake, low intake of calcium and potassium, alcohol consumption, 
psychosocial stress, low levels of physical activity and others.(Fauci, et al., 2008) 
1.2	  Pathophysiology	  of	  Hypertension	  	  
            
BP= CO X PR 
Equation 1- Blood Pressure 
Where: BP= blood pressure  CO= Cardiac Output PR= Peripheral Resistance 
 
And: 
 
 
Stroke Volume           Heart Rate          Vessel                     Vascular 
      (SV)                         (HR)                structure               vasodilation 
 
 
 
 
  Cardiac Output                  Peripheral Resistance 
            (CO)                                                     (PR) 
 
 
 
 
 
            
                          Blood Pressure 
Figure 1- Components of Blood Pressure 
 
Mechanisms to increase BP: 
• Increase in SV 
• Increase in HR 
• Increase pressure on vascular structure 
• Alteration in vascular function 
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1.2.1	  Intravascular	  Volume	  	  	  
The increase in BP is related to sodium linked to choride but not to the 
sodium without the cholide. Increase in NaCl intake and/or decreased capacity of 
excretion leads to an increase in  the intravascular volume thus increasing the 
cardiac output. Over time there is an adaptation with increase in vascular 
resistance, releasing of natriuretic peptide (that augment the renal sodium 
excretion) , high BP  leads to a higher glomerular filtration rate , decreasing the 
absorbing in the renal tubules, thus increasing sodium excretion, all these 
making the CO normal again. When an impaired capacity of Na excretion exists, 
higher BP are required to induce natriuresis and reach sodium balance. 
Increased neural activity to the kidney elevates renal tubular reabsorption 
of sodium. The higher concentration in plasma sodium in its turn may also lead 
to an increase in BP to try to augment the glomerular filtration rate in order to 
balance the sodium, thus making a vicious cycle. 
 Also some organs (brain, kidney) have an autoregulation of flow,i.e. they 
keep the flow to the organ steady, even when the intravascular volume is 
augmented. They manage to do it by increasing the resistance of the afferent 
arteries, but then this resistance is transmitted to the other vessels and leads to a 
higher BP. 
 
1.2.2	  Autonomic	  Nervous	  System	  	  	  
Short term BP are modulated by adrenergic reflexes while long term 
regulation are regarded as derived from adrenergic function (hormonal, volume 
factors). 
 Cardiovascular homeostasis are maintained due to pressure, volume and 
chemoreceptors. Norepinephrine (NE), epinephrine (EP) and dopamine (DA) are 
the endogenous cathecolamines and all of them are important in this process and 
they have different affinities to different receptors, but also the receptors has 
different functions. Thus, it is important to understand it in order to comprehend 
the action of different anti-hypertensive drugs.  
Norepinephrine has greater affinity to α receptors: 
α 1 receptors  are in the smooth muscle and elicits vasoconstriction  
	   15	  
α 2 receptors are a negative feedback to NE release, ie inhibits the NE      
release when linked to NE 
Epinephrine has better affinity to ß receptors 
ß 1 receptors stimulates increase in HR and strengthens the cardiac 
contraction, increasing CO, also this receptor increases the rennin release 
from the kidney 
ß 2 receptors relaxes the smooth muscle and leads to a vasodilation 
 
Also there is a downregulation of receptors when there is higher 
concentration of circulating catecholamines (the more catecholamine, the lower 
number of receptors and vice versa) 
 The reflex action on the blood pressure regulation occurs on a minute-to-
minute basis. There are baroceptors in the carotid sinuses and in aortic arch. So 
when the BP increases, there is an increase in these receptors firings leading to a 
decrease in the sympathetic outflow resulting in decreases in BP and HR. This 
effect is quite rapid and is the main responsible for the adjustment of the BP 
during postural changes, stress and changes in blood volume such as in a 
hemorrhage. But also this reflex is susceptible to adaptations, so in hypertensive 
patients this receptors tend to respond to higher BP levels. 
 
1.2.3	  Renin-­‐Angiotensin-­‐Aldosterone	  	  (see	  Figure	  2)	  	  	  
Renin is a substance that is produced in the segment of justaglomerular 
cells –in the segment of the renal afferent arteriole and in the macula densa close 
to the distal loop of Henle. There are 3 main stimuli to renin release: 
	  
1. Decrease in NaCl transport in the loop of Henle-also indicating low 
BP (sodium balance mechanism) 
2. Decrease pressure or decreased strech in the renal afferent arteriole 
(baroceptor)indicating low pressure and needs to elevate BP 
3. Sympathetic nervous stimulation via ß 1 receptors 
             And the release is inhibited by the opposite of the situations above. 
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 Renin activates the angiotensinogen to form angitensin I. An angiotensin 
converting enzyme (ACE) will , mainly in the pulmonary circulation, convert the 
angiotensin I in angiotensin II. This ACE also inactivates another vasodilator, the 
bradykinin. 
 
Angiotensin II has important role in hypertension due to many 
mechanisms: 
	  
• Acts primarily via angiotensin II type 1 receptor (AT1), leading to 
aldosterone secretion by the adrenal mucosa. Aldosterone is a 
mineralocorticoid that acts in the sodium reabsorption on the renal 
cortical collecting duct. It acts in the Na+/H+K+, increasing sodium 
reabsorption eliminating H+ and K+ resulting in hipocalemia and 
alkalosis. Moreover aldosterone also is a potent mitogen stimulating 
vascular smooth-muscle cell and myocyte growth.And it can also 
participate in the cardiac hypertrophy and congestive heart failure, 
independent of its action increasing the blood pressure. 
• May also play a role in the pathogenesis of atherosclerosis through 
a direct action on the vessel wall. And can cause vasoconstriction. 
Whereas angiotensin II receptor type 2 has the opposite effects, 
such as vasodilation, Na excretion and inhibition of cell growth and 
matrix formation and improves remodelling by stimulating vascular  
smooth cells apoptosis and contributes to the regulation of the 
glomerular filtration rate. Blockade of AT1 ellicits AT2 activity. 
 
The renin-angiotensin-aldosterone axis is not always the villain, when 
there is a situation of volume contraction or reduced NaCl intake, the 
homeostasis of the BP are achieved via this axis. 
  	  	  	  	  	  	  	  	  
	   17	  
	  
 
Renin 
	  	  
 
 
 
Bradykinin 
 
   ACE    
                               
     
 
 
           
Inactive 
peptides 
	  	   	   	   	   	   	   	   	  	   	   	  
                         via AT1                          AT2                       	   	  
	  
	  
	  
1.2.4	  Vascular	  mechanisms	  	  
Vascular compliance and the diameter are important determinants of BP 
and even small changes in vascular diameters leads to a significantly increase 
resistance. 
In hypertension there is structural, mechanical and functional changes that 
may reduce the lumen diameter in the arteries and arterioles.  
The lumen diameter also is dependent on the elasticity of the vessel- the 
higher the elasticity the higher the compliance, i.e.  vessels with high elasticity 
Angiotensinogen 
	  	  	  Angiotensin I 
     Angiotensin II 
  Aldosterone 
Figure 2- Renin-Angiotensin-Aldosterone axis 
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can take an increase in blood volume without changing very much the pressure. 
Hypertensive patients usually have arteriosclerosis making the arteries stiffer, 
and the stiffness of the arteries has a predictive value for cardiovascular events. 
The alterations in the vascular tone and vascular growth, modulated by 
intracellular pH, in hypertensive patients can be explained by : 
1. Increased Na leads to a increase in intracellular calcium (by action in 
the permeability ), increasing the vascular tone 
2. Alterations in pH caused by the Na+/H+ pump  leads to a greater 
sensibility to calcium by contractile apparatus, also the activity in 
this pump also increase the sensitivity to mitogens, thus stimulating 
the smooth muscle cell growth. 
  
 The vascular tone also is dependent on many vasoactive substance 
produced by the endothelial cells, such as the nitric oxide (NO) , a potent 
vasodilator. In hypertension this endothelium dependant vasodilation is impaired.  
 It is not known yet if these vascular abnormalities in hypertensive patients 
are primary or secondary to increased arterial BP, but weight loss, aerobic 
exercise and anti-hypertensive medicaments can improve them.  
 
1.3	  Target	  Organs	  in	  Hypertension	  	  
Hypertensive patients is at greater risk to all artheriosclerosis 
manifestations. And hypertension is an independent risk for heart failure, 
coronary artery disease, stroke, renal disease and peripheral artery disease.  
1.3.1	  Heart	  
Compromise of this organ is the principal cause of death among 
hypertensive population. 
 Heart disease in hypertension is due to  both structural and functional 
adaptations leading to left ventricular (LV) hypertrophy, diastolic dysfunction, 
congestive heart failure (CHF), atherosclerotic coronary disease , microvascular 
disease and cardiac arrhythmias. 
 Patients with LV hypertrophy have an elevated risk for coronary heart 
disease (CHD), CHF, stroke and sudden death. Adequate control can revert this 
process by reducing the LV hypertrophy. 
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1.3.2	  Brain	  
Hypertensive patients have an increased risk to have stoke either by brain 
infarction (85%) or  hemorrhage - intracerebral or subarachnoid -(15 %). And the 
incidence is proportional to the level of BP, particularly the systolic BP among 
those older than 65 years. Lowering the level of BP decreases the risk for stroke. 
Another burden of hypertension is the impairment of cognition in aging 
population may be due to either strategic localized infarct or multiple lacunar 
(subcortical white matter) infarction. Studies are investigating the extent of the 
benefit of treating hypertension for prevention of dementia. 
In malignant hypertension, failure in autoregulation of brain flow  may lead 
to encephalopathy with severe headache, nausea and vomiting and constitute an 
emergency situation as it can progress to stupor, coma, seizures and death 
within hours. 
 
1.3.3	  Kidney	  
Hypertension is a risk factor for renal damage and can lead to end stage 
renal disease (ESRD), and here also the risk is proportional to the increase in BP 
levels above optimal, and also has racial differences, being the black men at 
higher risk than white men at the same BP level. 
Microalbuminuria (urine albumin/creatine ratio 30- 300mg/g) and also 
macroalbuminuria ( urine albumin/creatine ratio >300mg/g) are early markers for 
kidney injury and are risk factoer for progression of the disease. 
 
1.3.4	  Peripheral	  arteries	  
Alterations in structure and/or function of the arteries are part of the 
pathogenesis of hypertension, but to make matters worse, blood vessels can be 
also a target for damages by long term elevated BP leading to a vicious cycle. 
Those patients with lesion in arteries of the legs has greater risk of CVD. 
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1.4	  Diagnosis	  of	  Hypertension	  	  	  
Diagnosis of Hypertension should: 
 
1) Establish the blood pressure levels- as the level of blood  pressure is not 
constant , the diagnosis should be based on multiple blood pressure 
measurements, taken in different occasions over a period of time. 
Nevertheless if the patient has a marked high blood pressure, has a high 
or very high cardiovascular risk profile, signs of damage in hypertension 
related organ, then the revaluation should be done in a shorter period 
(weeks or days)(ESH/ESC, 2007) 
 
2) Identify secondary causes of hypertension (as related above) 
 
 
3) Assessment of overall cardiovascular risk factors, target organ damage 
and concomitant diseases (blood pressure level, diabetes mellitus, 
metabolic syndrome, one or more of the following subclinical organ 
damages: ECG with strain pattern; ecocardiographic (concentric) left 
ventricular (LV) hypertrophy; ultrasound with evidence of  thickening of 
carotid  artery wall or plaque; increased arterial stiffness; moderate 
increase in serum creatinine clearance; microalbuminuria or proteinuria or 
with cardiovascular or renal disease. 
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1.4.1	  Recommendations	  when	  measuring	  the	  blood	  pressure: 
	  
Figure 3- Recommendations for Blood Pressure Measurement 
From:(ESH/ESC, 2007) 
1.4.2	  Ambulatory	  blood	  pressure	  	  
Provides information on 24-hour average blood pressure as well as on 
mean values over more restricted periods such as the day, night or morning.  The 
physician should not substitute the conventional BP measure but some reports 
showed that office taken BP has limited relation with the 24-hour average(Mancia, 
et al., Twenty-four hour ambulatory blood pressure in the Hypertension Optimal 
Treatment (HOT)study, 2001)(Mancia, Omboni, Ravogli, Parati, & Zanchetti, 
1995)(Mancia, et al., 2007). 
Some advantages of 24-ABPM over office only measure: 
-It has a higher reproducibility over time(Coats, Radaelli, Clark, 
Conway, & Sleight, 1992)(Mancia, Ulian, Parati, & Trazzi, 1994) 
-Absent or insignificant ‘white coat’ and placebo effect(Staessen, et 
al., 1994)(Mancia, Omboni, Parati, Ravogli, Vilani, & Zanchetti, Lack 
of placebo effect on ambulatory blood pressure, 1995) 
-Better prognostic value(ESH/ESC, 2007) 
-Gives information on blood pressure variability-	  (standard deviation	  around	  mean	   values),	   the variability of blood pressure may have a 
accurately than clinic blood pressure the extent of blood
pressure reduction induced by treatment, because of a
higher reproducibility over time97,98 and an absent or negli-
gible ‘white coat’99 and placebo effect.100,101 Although
some of the above advantages can be obtained by increasing
the number of office blood pressure measurements,82,98
24-hour ambulatory blood pressure monitoring may be
useful at the time of diagnosis and at varying intervals
during treatment. Effort should be made to extend ambulat-
ory blood pressure monitoring to 24 hours in order to obtain
information on both daytime and nighttime blood pressure
profiles, day-night blood pressure difference, morning
blood pressure rise and blood pressure variability. Daytim
and nighttime blood pressure values and changes by treat-
ment are related to each other,78,79 but the prognostic
value of nighttime blood pressure has been found to be
superior to that of daytime blood pressure.87,89–92,94 In
addition, subjects in whom nocturnal decrease in blood
pressure is blunted (non-dippers)102 have been reported to
have a greater prevalence of organ amage and a l ss
favourable outcome, although in some studies the prog-
nostic value of this phenomenon was lost when multi-
variate analysis included 24-h average blood
pressure.87,88,90,92,93,103–106 Evidence is also available that
cardiac and cerebrovascular events have a peak prevalence
in the morning,107–110 possibly in relation to the sharp blood
pressure rise occurring at awaki g from sleep,72,111–113 as
well as to an increased platelet aggregability, a reduced
fibrinolytic activity and a symp thetic activation.114–118
Worsening of organ damage and the incidence of events
have also been related to blood pressure variability as quan-
tified by the standard deviation around mean values.119–121
Although in these studies the role of confounding factors
was not always excluded, an independent role of blood
pressure variability has recently been confirmed by a long-
term observational study.122
When measuring 24-hour blood pressure75 care should be
t ken to:
† Use only devices validated by international standardized
protocols.
† Use cuffs of appropriate size and compare the initial
values with those from a sphygmomanometer to check
that the differences are not greater than +5 mmHg.
† Set the automatic readings at no more than 30 min inter-
vals to obtain an adequate number of values and have
most hours represented if some readings are rejected
because of artefact.
† Automatic deflation of the equipment should be at a rate
of no more than 2 mmHg/s.
† Instruct the patients to engage in normal activities but to
refrain from strenuous exercise, and to keep the arm
extended and still at the time of cuff inflations.
Box 2 Blood pressure (BP) measurement
When measuring BP, care should be taken to:
† Allow the patients to sit for several minutes in a quiet
room before beginning BP measurements
† Take at least two measurements spaced by 1–
2 minutes, and additional measurements if the first
two are quite different
† Use a standard bladder (12–13 cm long and 35 cm
wide) but have a larger and a smaller bladder available
for fat and thin arms, respectively. Use the smaller
bladder in children
† Have the cuff at the heart level, whatever the position
of the patient
† Use phase I and V (disappearance) Korotkoff sounds to
identify systolic and diastolic BP, respectively
† Measure BP in both arms at first visit to detect possible
differences due to peripheral vascular disease. In this
instance, take the higher value as the reference one
† Measure BP 1 and 5 min after assumption of the stand-
ing position in elderly subjects, diabetic patients, and
in other conditions in which postural hypotension may
be frequent or suspected
† Measure heart rate by pulse palpation (at least 30 sec)
after the second measurement in the sitting position
Box 3 Position statement: Ambulatory and
home BP measurements
Ambulatory BP
† Although office BP should be used as reference, ambu-
latory BP may improve prediction of cardiovascular risk
in untreated and treated patients
† Normal values are different for office and ambulatory
BP (Table 5)
† 24-h ambulatory BP monitoring should be considered,
in particular, when
- considerable variability of office BP is found over the
same or different visits
- high office BP is measured in subjects otherwise at
low total cardiovascular risk
- there is a marked discrepancy between BP values
measured in the office and at home
- resistance to drug treatment is suspected
- hypotensive episodes are suspected, particu larly in
elderly and diabetic patients
- office BP is elevated in pregnant women and pre-
eclampsia is suspected
Home BP
† Self-measurement of BP at home is of clinical value
and its prognostic significance is now demonstrated.
These measurements should be encouraged in order
to:
- provide more information on the BP lowering effect
of treatment at trough, and thus on therapeutic
coverage throughout the dose-to-dose time interval
- improve patient’s adherence to treatment regimens
- there are doubts on technical reliability/
environmental conditions of ambulatory BP data
† Self-measurement of BP at home should be
discouraged whenever:
- it causes anxiety to the patient
- it induces self- odificati n of the treatment regimen
† Normal values are different for office and home BP
(Table 5)
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prognostic value in hypertension treatments. (Mancia, et al., 
2007)(Mancia, Prognostic value of long-term blood pressure 
variability:the evidence is growing, 2011) 
1.5	  Classification	  of	  Hypertension	  	  
1.5.1	  According	  to	  BP	  levels	  	  
According to the 2003 and 2009 ESH (European Society of 
Hypertension)/ESC (European Society of Cardiology) the blood pressure is 
classified as this table shows: 
 
	  
Table 1-Classification of Hypertension (ESH/ESC 2007) 
(ESH/ESC, 2007) 
Also there are some points to be considered when classifying the blood 
pressure level: 
-When systolic blood pressure (SBP) and diastolic blood pressure (DBP) are 
in different categories, always consider the higher category for all purposes 
-Isolated systolic blood pressure should be graded according to the same 
systolic blood pressure value indicated for systolic-diastolic hypertension, 
and the aorta, is a more precise assessment and may
improve on these limitations.
In practice, classification of hypertension and risk assess-
ment (see sections 2.2 and 2.3) should continue to be based
on systolic and diastolic blood pressures. This should be defi-
nitely the case for decisions concerning the blood pressure
threshold and goal for treatment, as these have been the
criteria employed in randomized controlled trials on isolated
systolic and systolic-diastolic hypertension. However, pulse
pressure may be used to identify elderly patients with systo-
lic hypertension who are at a particularly high risk. In these
patients a high pulse pressure is a marker of a pronounced
increase of large artery stiffness and therefore advanced
organ damage28 (see section 3.6).
2.2 Classification of hypertension
Blood pressure has a unimodal distribution in the population29
as well as a continuous relationship with cardiovascular risk
down to systolic and diastolic levels of 115–110 mmHg and
75–70 mmHg, respectively.7,11 This fact makes the word
hypertension scientifically questionable and its classification
based on cutoff values arbitrary. However, changes of a
widely known and accepted terminology may generate con-
fusion while use of cutoff values simplifies diagnostic and
treatment approaches in daily practice. Therefore the classi-
fication of hypertension used in the 2003 ESH/ESC Guidelines
has been retained (Table 1) with the following provisos:
1. when a patient’s systolic and diastolic blood pressures
fall into different categories the higher category should
apply for the quantification of total cardiovascular risk,
decision about drug treatment and estimation of treat-
ment efficacy;
2. isolated systolic hyp rtension should be graded (grades 1,
2 and 3) according to the same systolic blood pressure
values indicated for systolic-diastolic hypertension.
However, as mentioned above, the association with a
low diastolic blood pressure (e.g. 60–70 mmHg) should
be regarded as an additional risk;
3. the threshold for ypertension (and the need for drug
treatme t) should b considered as flexible based n
the level and profile of total cardiovascular risk. For
example, a blood pressure value may be considered as
unacceptably high and in need of treatment in high risk
states, but still acceptable in low risk patients. Support-
ing evidence for this statement will be presented in the
section on therapeutic approach (Section 5).
The USA Joint National Committee Guidelines (JNC 7) on
hypertension published in 200330 unified the normal and
high normal blood pressure categories into a single entity
termed ‘prehypertension’. This was based on the evidence
from the Framingham study31,32 that in such individuals the
chance of developing hypertension is higher than in those
with a blood pressure ,120/80 mmHg (termed ‘normal’
blood pressure) at all ages. The ESH/ESC Committee has
decided not to use this terminology for the following
reasons: 1) even in the Framingham study the risk of develop-
ing hypertension was definitely higher in subjects with high
normal (130–139/85–89 mmHg) than in those with normal
blood pressure (120–129/80–84 mmHg)32,33 and therefore
there is little reason to join the two groups together; 2)
given the ominous significance of the word hypertension for
the layman, the term ‘prehypertension’ may create anxiety
and request for unnecessary medical visits and examinations
in many subjects;34 3) most importantly, although lifestyle
changes recommended by the 2003 JNC 7 Guidelines for all
prehypertensive individuals may be a valuable population
strategy,30 in practice this category is a highly differentiated
one, with the extremes consisting of subjects in no need of
any intervention (e.g. an elderly individual with a blood
pressure of 120/80 mmHg) as well as of those with a very
high or high risk profile (e.g. after stroke or with diabetes)
in whom drug treatment is required.
In conclusion, it might be appropriate to use a classification
of blood pressure without the term ‘hypertension’. However,
this has been retained in Table 1 for practical reasons and
with the reservation that the real threshold for hypertension
must be considered as flexible, being higher or lower based
on the total cardiovascular risk of each individual. This is
further illustrated in section 2.3 and in Figure 1.
2.3 Total cardiovascular risk (Box 1)
2.3.1 Concept
For a long time, hypertension guidelines focused on blood
pressure values as the only or main variables determining
the need and the type of treatment. Although this approach
was maintained in the 2003 JNC 7 Guidelines,30 the 2003
ESH-ESC Guidelines3 emphasized that diagnosis and manage-
ment of hypertension should be related to quantification of
total (or global) cardiovascular risk. This concept is based
on the fact that only a small fraction of the hypertensive
population has an elevation of blood pressure alone, with
the great majority exhibiting additional cardiovascular risk
factors,35–39 with a relationship between the severity of the
blood pressure elevation and that of alterations in glucose
and lipid metabolism.40 Furthermore, when concomitantly
present, blood pressure and metabolic risk factors potentiate
each other, leading to a total cardiovascular risk which is
greater than the sum of its individual components.35,41,42
Finally, evidence is available that in high risk individuals
thresholds and goals for antihypertensive treatment, as
well as other treatment strategies, should be different from
those to be implemented in lower risk individuals.3 In order
Table 1 Definitions and classification of blood pressure (BP)
levels (mmHg)
Category Systolic Diastolic
Optimal ,120 and ,80
Normal 120–129 and/or 80–84
High normal 130–139 and/or 85–89
Grade 1 hypertension 140–159 and/or 90–99
Grade 2 hypertension 160–179 and/or 100–109
Grade 3 hypertension !180 and/or !110
Isolated systolic
hypertension
!140 and ,90
Isolated systolic hypertension should be graded (1, 2,3) according to
systolic blood pressure values in the ranges indicated, provided that dias-
tolic values are ,90 mmHg. Grades 1, 2 and 3 correspond to classification
in mild, moderate and severe hypertension, respectively. These terms
have been now omitted to avoid confusion with quantification of total
cardiovascular risk.
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however the association with low diastolic blood pressure (60-70mmHg) should 
be regarded as an additional risk 
 -Threshold for hypertension should be considered based on the level and 
profile of total cardiovascular risk.(ESH/ESC, 2007) 
 Moreover, different from the previous recommendations, the ESH/ESC now 
states that the blood pressure should not be evaluated as an isolate factor but in 
relationship to their total cardiovascular risk, i.e. associated concomitantly with 
metabolic risk factors because the risk to end organ damage and disease is 
greater than the sum of the individual components, this may occur because 
obesity, particularly abdominal obesity is very frequently associated with 
hypertension, dyslipidaemia and insulin resistance. The constellation of 
hypertension, dyslipidaemia and insulin resistance is the metabolic syndrome. 
Insulin resistance is also linked to an alteration in endothelium, dysbalancing the 
production of mediators that regulate platelet aggregation, coagulation and 
fibrinolysis and vessel tone. So when these risk factors cluster its potentiates the 
risk for CHD, stroke, diabetes making the mortality due to CVD even higher.  
 
Table 2-Stratification of Cardiovascular Risk 
	  “	  Stratification	  of	  CV	  Risk	  in	  four	  categories.	  SBP:	  systolic	  blood	  pressure;	  DBP:	  diastolic	  blood	  pressure;	   CV:	   cardiovascular;	   HT:	   hypertension.	   Low,	   moderate,	   high	   and	   very	   high	   risks	  refer	   to	   10-­‐year	   risk	   of	   a	   CV	   fatal	   or	   non-­‐fatal	   event.	   The	   term	   ‘added’	   indicates	   that	   in	   all	  categories	   risk	   is	   greater	   than	   average.	   OD:	   subclinical	   organ	   damage;	   MS:	   metabolic	  syndrome.	   The	   dashed	   line	   indicates	   how	   definition	   of	   hypertension	   may	   be	   variable,	  depending	  on	  the	  level	  of	  total	  CV	  risk.	  “	  
(European Heart Journal (2007) 28, 1462–1536 doi:10.1093/eurheartj/ehm236 ) 
 
to maximize cost-efficacy of the management of hyperten-
sion the intensity of the therapeutic approach should be
graded as a function of total cardiovascular risk.43,44
2.3.2 Assessment
Estimation of total cardiovascular risk is simple in particular
subgroups of patients such as those with 1) a previous diag-
nosis of cardiovascular disease, 2) type 2 diabetes, 3) type 1
diabetes, and 4) individuals with severely elevated single
risk factors. In all these conditions the total cardiovascular
risk is high, calling for the intense cardiovascular risk redu-
cing measures that will be outlined in the following sections.
However, a large number of hypertensive patients does not
belong to one of the above categories and identification of
those at high risk requires the use of models to estimate
total cardiovascular risk so as to be able to adjust the inten-
sity of the therapeutic approach accordingly.
Several computerized methods have been developed for
estimating total cardiovascular risk, i.e. the absolute
chance of having a cardiovascular event usually over 10
years. However, some of them are based on Framingham
data45 which are only applicable to some European popu-
lations due to important differences in the incidence of cor-
onary and stroke events.12 More recently, a European model
has become available based on the large data-base provided
by the SCORE project.46 SCORE charts are available for high
and low risk countries in Europe. They estimate the risk of
dying from cardiovascular (not just coronary) disease over
10 years and allow calibration of the charts for individual
countries provided that national mortality statistics and esti-
mates of the prevalence of major cardiovascular risk factors
are known. The SCORE model has also been used in the Heart-
Score, the official ESC management tool for implementation
of cardiovascular disease prevention in clinical practice.
This is available on the ESC Web Site (www.escardio.org).
The 2003 ESH/ESC Guidelines3 classified the total cardio-
vascular risk based on the scheme proposed by the 1999
WHO/ISH Guidelines on hypertension2 with the extension
to subjects with ‘normal’ or ‘high normal’ blood pressure.
This classification is retained in the present Guidelines
(Figure 1). The terms ‘low’, ‘moderate’, ‘high’ and ‘very
high’ risk are used to indicate an approximate risk of cardi-
ovascular morbidity and mortality in the coming 10 years,
which is somewhat analogous to the increasing level of
total cardiovascular risk estimated by the Framingham45 or
the SCORE46 models. The term ‘added’ is used to emphasize
that in all categories relative risk is greater than average
risk. Although use of a categorical classification provides
data that are in principle less precise than those obtained
Figure 1 Stratification of CV Risk in four categories. SBP: systolic blood pressure; DBP: diastolic blood pressure; CV: cardiovascular; HT: hypertension. Low,
moderate, high and very high risk refer to 10 year risk of a CV fatal or non-fatal event. The term ‘added’ indicates that in all categories risk is greater than
average. OD: subclinical organ damage; MS: metabolic syndrome. The dashed line indicates how definition of hypertension may be variable, depending on
the level of total CV risk.
Box 1 Position statement: Total cardiovascular
risk
† Dysmetabolic risk factors and subclinical organ damage
are common i hyper ensive patients.
† All patients should be classified not only in relation to
the grades of hypertension but also in terms of the
total cardiovascular risk resulting from the coexistence
of different risk factors, organ damage and disease.
† Decisions on treatment strategies (initiation of drug
treatment, BP threshold and target for treatment,
use of combination treatment, need of a statin and
other non-antihypertensive drugs) all importantly
depend on the initial level of risk.
† There are several methods by which total cardiovascular
risk can be assessed, all with advantages and limitations.
Categorization of total risk as low, moderate, high, and
very high added risk has the merit of simplicity and can
therefore be recommended. The term ‘added risk’
refers to the risk additional to the average one.
† Total risk is usually expressed as the absolute risk of
having a cardiovascular event within 10 years.
Because of its heavy dependence on age, in young
patients absolute total cardiovascular risk can be low
even in the presence of high BP with additional risk
factors. If insufficiently treated, however, this con-
dition may lead to a partly irreversible high risk con-
dition years later. In younger subjects treatment
decisions should better be guided by quantification of
relative risk, i.e. the increase in risk in relation to
average risk in the population.
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1.5.2	  According	  to	  aetiology	  	  
Essential or Primary Hypertension is when there is no identifiable cause (80-95% 
of the cases) or Secondary Hypertension when it is secondary to another 
pathology such as: 
• Renal disease (parenchymal diseases, renal cysts, polycystic renal disease, 
renal tumours) 
•  Genetic causes, Reno vascular hypertension (atherosclerotic, fibro 
muscular dysplasia) 
• adrenal (primary hyperaldosteronism, Cushing’s syndrome, 17α hydrolase 
deficiency, 11ß hydrolase deficiency, 11-hydroxysteroid dehydrogenase 
deficiency-liquorice, pheocromocytoma)  
• Aorta coarctation 
• Obstructive sleep apnoea 
• Associated with pregnancy (eclampsia, preeclampsia) 
• Neurogenic (psychogenic, diencephalic syndrome, familial dysautonoma, 
polyneuritis –acute porphyria, lead poisoning-, acute increased intracranial 
pressure, acute spinal cord section)  
• Endocrine (Hypothyroidism, hyperthyroidism, hypercalemia, acromegaly) 
• medications (high dose estrogens, adrenal steroids, decongestants, 
appetite suppressants, cyclosporine, tricyclic antidepressants, monoamine 
oxidase inhibitors, erythropoietin, nonsteroidal anti-inflammatory agents, 
cocaine)  
The essential hypertension is the most common form of hypertension, 
occurring in general after the 4th decade of life, and its actual cause is unknown, 
and a multifactorial hypothesis is probable. Many unknown factors interact to 
lead to an increase in total peripheral resistance due to a change in the arterioles, 
thus leading to an elevation of diastolic pressure that leads to an increase also in 
systolic pressure in response to a pressor stimulus. When there is decrease 
compliance in the arteries, there is an increase in systolic pressure and decrease 
in diastolic pressure (as we see in some elderly patients in the isolated systolic 
hypertension)(Randal, 1991). Before the structure of the arterioles and/or arteries 
changes there is a functional alteration and the vasoconstriction can due to an 
excessive production or low decrease in ‘hypertensive’ factors such as 
rennin/angiotensin/aldosterone, vasopressin, endotelin, sympathetic nervous 
system-adrenalin, norepinephrine. 
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1.5	  Conventional	  Therapy	  of	  Hypertension	  (ESH/ESC,	  2007):	  
 
As seen above, the therapy of hypertension has to consider not only the 
blood pressure levels but also the patient age, associated morbidities (diabetes 
mellitus, renal disease, coronary artery disease, end organs damage etc.), thus 
accessing the overall cardiovascular risk. An observational study of more than 1 
million subjects indicated that death from both coronary heart disease and stroke 
increases linearly with the blood pressure levels.(Lewington, Clarke, Qizilbash, 
Peto, & Collins, 2002) 
 
 
Table 3-Recommended Conventional therapy for Hypertension 	  	  
	  
(ESH/ESC, 2007) 
 
 
Lifestyle change includes smoking cessation, weight reduction (and 
stabilization), reduction in alcohol and salt intake, physical exercise, increase in 
fruit and vegetable consumption, decrease in saturated and total fat intake, 
periodically reinforced recommendations, close follow up. 
to a recent meta-analysis,460 which reports less new dia-
betes in the placebo than either in the diuretic or the
b-blocker group. Other placebo controlled trials in con-
ditions different from hypertension (high cardiovascular
risk, chronic heart failure) have also shown a lower new
diabetes incidence in patients treated with ACE inhibi-
tors306,461,462 or angiotensin receptor antagonists463 than in
placebo patients, but in all these trials placebo (as well as
the active agent) was added on top of multiple drug thera-
pies, among which diuretics and b-blockers predominated
at baseline and could be varied to an unknown extent
during the trial. The same confounding factor makes
interpretation of the recent negative finding of the DREAM
trial464 difficult: in this trial administration of ramipril to
subjects with impaired glucose toler nce was not associated
with a lower subsequent incidence of diabetes than admin-
istration of placebo. However, almost half of DREAM sub-
jects had hyperten ion and one third dyslipidaemia, and a
large number of them received various types of antihyper-
tensive agents and lipid lowering drugs. A very recent
network meta-analysis of 22 trials with more that 160,000
participants460 has calculated that the association of antihy-
pertensive agents with new diabetes is lowest for angioten-
sin receptor antagonists and ACE inhibitors followed by
calciu antagonists and placebo, b-blockers and diuretics
in rank order.
It has been suggested that treatment-related new dia-
betes may not have the same adverse prognostic effect as
‘spontaneously’ occurring diabetes. This claim is based on
the observation that during controlled trials patients devel-
oping diabetes have not had a greater morbidity than
patients without new onset diabetes.322 However, it is
known that cardiovascular complications follow the onset
of diabetes after a time delay (more than 10 years) longer
than that possible in controlled randomized trials.465
Longer term (16–30 years) observational studies have
shown a significantly higher incidence of cardiovascular
complication in patients having developed diabetes during
antihypertensive treatment predominantly with diuretics
and/or b-blockers.466–470 A notable exception is a 14-year
follow up of the SHEP study,459 during which newly occurring
diabetes among actively treated patients (chlorthalidone
plus, eventually, atenolol) was reported not to be associated
with increased mortality. A limitation of the above long-
term follow-up studies is that microvascular endpoints,
i.e. complications highly related to hyperglycaemia, were
not assessed. Furthermore, in long-term studies follow-up
cannot be done under controlled conditions and confounding
factors may be frequent and unknown. Therefore the claim
that treatment-induced and ‘spontaneous’ onset diabetes
may be prognostically different appears impossible to
confirm or confute. In the absence of more compelling
evidence of an inn cuous nature, the increased diabetes
incidence with some antihypertensive agents currently
raises concerns that would be imprudent to disregard.
5. Therapeutic approach
5.1 When to initiate antihypertensive treatment
The decision to start antihypertensive treatment should be
based on two criteria, i.e. 1) the level of systolic and dias-
tolic blood pressure as classified in Table 1, and 2) the
level of total cardiovascular risk. This is illustrated in
Figure 2.
All patients in whom repeated blood pressure measure-
ments show grade 2 or 3 hypertension are definite candi-
dates for antihypertensive treatment because, as detailed
in the 2003 ESH/ESC Guidelines,3 a large number of
placebo controll d trial have conclusively demonstrated
that in patients with these blood pressure values blood
Figure 2 Initiation of antihypertensive treatment.
ESC and ESH Guidelines1486
 by guest on September 24, 2012
http://eurheartj.oxfordjournals.org/
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An important message from the newest ESH/ESC Guidelines 2011 is that 
the management of individual components of cardiovascular risk such as 
smoking, diet, exercise, blood pressure and lipids have impacts on the total  risk, 
than if the control of one of them is not optimal (i.e. hypertension in the elderly) 
the total risk can still be reduced by reducing other risk factors such as smoking 
or lipids. (ESH/ESC, 2011) 
 
There are five main classes of drugs to be used, alone or in combination, 
always aiming to lower the BP: Thiazide diuretics, calcium antagonists, ACE 
(angiotensin conversor enzyme) inhibitors, angiotensin receptor antagonists and 
ß-blockers. In patients with diabetes or metabolic syndrome ß-blockers especially 
with thyazide diuretic should be avoided. The drug choice should be made taking 
into account the compliance (once a day is better than 3 times a day), side 
effects, and there are some pathologies that have some preferred drugs to be 
used as antihypertensive. 
 
According to ESH/ESC the therapy in hypertension aims to achieve 
maximum reduction in long term total cardiovascular disease risk, treating not 
only the blood pressure but all others reversible factors involved, thus reducing it 
at least to 140/90mmHg and even to lower values if tolerated, lower than 130/80 
in diabetic patients and others with very high risk for CVD cardiovascular disease 
(stroke, myocardial infarction, renal dysfunction, proteinuria), and to achieve the 
goal level of BP, the treatment should start before significant damage develops. 
 
The American Heart Association (AHA) and the American College of 
Cardiology (ACC) in its Expert Consensus Document on Hypertension in the 
Elderly in 2011, recommended a different approach to patients above 55years, 
considering their comorbilities, according to this fluxogram: 
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Figure 4-AHA/ACC recommendations for BP in patients above 55 years 
 
(ACC/AHA, 2011) 
 
Various publications have shown poor compliance to prescribed 
antihypertensive medicament, being this fact responsible for the lack of BP 
control(Yiannakopoulou, 2005). In the first year of therapy only 60% of the 
patients will continue the medication (Caro, Speckman, Raggio, & Jackson, 
1999)(Massaglia, et al., 2005), and after 5-10 years as much as 60% will abandon 
their prescription for hypertension(Caro, Speckman, Raggio, & Jackson, 1999). In 
the ALLHAT trial, prospectively, about 34% of the patients remained with 
unsatisfactory blood pressure control in spite of in average 2 medications and 
overall nearly half of the patients would have required 3 or more drugs, and at 
the end only2/3 of the participants had their SBP lowered to 140mmhg although 
92% has the DBP of 90mmHg.(ALLHAT officers and col, 2002). As hypertension is 
amiloride was equivalent to nifedipine gastrointestinal thera-
peutic system in preventing CV adverse outcomes in IN-
SIGHT (Intervention as a Goal in Hypertension Treatment)560
among patients 55 to 80 years of age with hypertension.
4.2.2.1.2. Beta-Adrenergic Blockers. Although beta blockers
have been used for hypertension in the elderly for years, evidence
for benefit has not been convincing.14–16,18,327 A meta-analysis of 10
studies comparing beta blockers and diuretics in patients!60 years
Figure 10. Algorithm for treatment of
hypertension in the elderly. ACEI indi-
cates angiotensin-converting enzyme
inhibitor; ALDO ANT, aldosterone an-
tagonist; ARB, angiotensin receptor
blocker; BB, beta blocker; CA, calcium
antagonist; CAD, coronary artery dis-
ease; CVD, cardiovascular disease;
DBP, diastolic blood pressure; RAS,
renin-angiotensin system; SBP, systolic
blood pressure; and THIAZ, thiazide
diuretic. Modified from Chobanian
et al.22
Table 6. Continued
Drug Class/Drug Interacting Drug Mechanism Consequence Prophylaxis
Angiotensin-converting enzyme inhibitor
ACEI class effect Excess diuretics; rare in
hypertension
High renin levels in overdiuresed
patients; volume depletion
First-dose hypotension; risk of renal
failure
Reduce diuretic dose; correct
volume depletion
Potassium-sparing diuretics;
spironolactone
Added potassium retention Hyperkalemia Avoid combination or use
with care
NSAIDs Less vasodilation Less BP and 2 less antifailure effect Avoid if possible
Aspirin Less vasodilation Less HF effects Low-dose aspirin
Loop diuretics Possible interference with tubular
secretion
Lessened diuretic effect of furosemide Consider alternate ACEI
Captopril (C) Immunosuppressive drugs,
procainamide-hydralazine
Added immune effects Increased risk of neutropenia Avoid combination; check
neutrophils
Probenecid (P) P inhibits tubular secretion of C Small rise in C levels Decrease C dose
Angiotensin receptor blockers
ARB class effect Excess diuretics; rare in
hypertension
High renin levels in overdiuresed
patients; volume depletion
First-dose hypotension; risk of renal
failure
Reduce diuretic dose; correct
volume depletion
Vasodilators Beta blockers (hepatically
metabolized)
Hepatic shunting Beta-blocker metabolism 2; blood
levels 1
Propranolol; metoprolol dose
2
Hydralizine Nitrates (N) Renal blood flow 1; added
vasodilation; free radicals scavenged
Less N tolerance (benefit); risk of
excess hypotension
Start with low dose of an
alpha blocker or
dihydropyridine; calcium
blocker
Verapamil Hepatic metabolism Synergistic antihypertensive effect Adjust doses
Cilostazol (C) Inhibition of P450 3A4; diltiazem,
verapamil, erythromycin,
ketoconazole, cyclosporine
2 hepatic interaction 1 C levels, risk of increased mortality
in HF
Lessen C dose or avoid
ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; AV, atrioventricular; BP, blood pressure; CHF, congestive heart failure;
CYP2D6, cytochrome P450 2 D6; ECG, electrocardiogram; HB, heart block; HF, heart failure; IV, intravenous; LV, left ventricle; NSAIDs, nonsteroidal anti-inflammatory
drugs; SA, sinoatrial; 1, increase; and 2, decrease.
Modified from Opie and Frishman.540
2472 Circulation May 31, 2011
 by guest on September 24, 2012http://circ.ahajournals.org/Downloaded from 
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a chronic disease, the treatment is required for a lifetime. The more increases the 
number pills and the complexity of dosage the poorer is the adherence to the 
treatment. Also when more drugs are combined it increases the possibility of side 
effects. Moreover change the life style is another difficult goal to reach.  Frequent 
visit to the clinic augments adhesion to the treatment.(Stason, et al., 1994)  
The use of acupuncture could help overcome these difficulties, by either 
diminishing or substituting the amount of drug required, and also because with 
frequent visits to the clinic it eases the compliance to the treatment (drugs 
and/or adjustment of lifestyle). 
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2.The	  Heidelberg	  Model	  of	  TCM	  or	  TCM	  as	  novel	  vegetative	  medicine	  	  
Traditional Chinese Medicine is a “system of sensations and findings 
designed to establish a functional vegetative state of the body and this state can 
be treated by Chinese pharmacotherapy, acupuncture, Chinese manual therapy 
(Tuina), Qi gong (biofeedback) or dietetics”(Greten H. , Understand TCM Scientific 
Chinese Medicine- The heidelberg Model, 2010 5th ed)   
In 1989, Kroenke and Mangelsdorf observed that almost 85% of the 
complaints in the outpatient clinic failed to demonstrate an organic cause, thus it 
could not be correlated to a measurable laboratory test.(Kroenke & Mangelsdorff, 
1989) 
Usually these inexplicable complaints could be pointed to psychosomatic 
disorders. Around 60-80% of the patients that have chronic complaints search for 
help of complementary medicine.(Greten H. , Understand TCM Scientific Chinese 
Medicine- The heidelberg Model, 2010 5th ed). 
The bases for the integration of the Chinese medicine into western world 
are: 
-Rational concept of TCM (rationally accessible) 
-Scientific proof of efficacy and safety 
-Quality control to be put on the basis of developing knowledge in this 
medical system 
(Greten H. , 2006) 
Aiming to allow a rational approach to Chinese medicine. Prof Greten 
developed the Heidelberg Model of TCM as a scientific model, based on prof. 
Porkert previous works (Porkert, 1983)(Porkert M. , 1974)(Porkert M. a., 1995) 
relying on primary Chinese sources. The precise Latin terminology utilized in this 
HD Model therefore is derived from these previous works. 
Leibniz’s analysis of the oldest book of the mankind -I Ging (“the Book of 
Changes”) explained the logical model of system biology using mathematical 
language - binary numbers. Based on this analysis prof. Greten developed a new 
view of Chinese Medicine. Thus yin is a black (discontinuous) bar and yang is 
white (continuous) bar and they form monogram, bigram, trigram, and they can 
be used to describe also circular processes.(Greten H. , 2006)  
There is evidence that in Classical China, even before the Yellow Emperor’s 
Classic, these regulatory fluctuations were described by circulatory functions in a 
	   30	  
simplistic manner resembling a sinus wave. This wave is part of the so- called 
monad (Leibniz) or Taiji sign  
  
Figure 4- Taiji Sign 
 
 
(Greten H. , Understand TCM Scientific Chinese Medicine- The heidelberg Model, 
2010 5th ed) 
 
 
Most of the regulatory processes describe periodical fluctuations of the 
actual value around a target value. Accordingly, as a vegetative system also is a 
regulatory process, one could categorize the symptoms leading to the orb- 
“group of diagnostically relevant signs that indicates the functional state of a 
body island (body region), which correlates with the functional properties of the 
conduit”(Greten H. , Understand TCM Scientific Chinese Medicine- The heidelberg 
Model, 2010 5th ed). 
To exemplify this situation we could use a model of water basin with an 
electric heater, which is regulated by a thermostat. A target value in this case 
could be 37ºC. 
!
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It is in such a sinusoidal course that almost all biological systems are regulated. For 
this reason, this regulatory curve must be considered in the evaluation of many biological 
phenomena. TCM has developed its own language to describe such changes around the 
set point, which could be applied to the regulation of autonomic nervous system in the 
human body: Yang-states are above the set point; Yin-states are below the set point. The 
phases (EPs) designate the sections (quadrants) of this sinusoid curve  
A sine curve can also be seen as a circular function. Graphically, if a circle is drawn 
around the whole picture, in which the sine curve is included, the result is the Fou qi 
character. This character comes from the Song dynasty (960-1279 AD). The signs in the 
Fou qi character have thus the basic mathematical meaning of the description of a circular 
motion (figure 6). Yang is therefore includes the wood and fire evolutionary phases; yin 
includes metal and water phases. This model can also be applied to explain t0-F.4)>7:;G
as vegetative effective directions, the concept of Yin-deficiency and the six-stage theory of 
<0-F"0)6/)6=6G [3]. 
 
 
Figure 6. A sinusoid wave is a circular function 
around a shall-be value in biological systems. 
Graphically, the Fou qi emblem is drawn. This well 
known sign of Yin/Yang may enclose a mathematical 
meaning. Yin and yang are terms of regulation that 
can be further differentiated in evolutive phases (e.g. 
F?77,G 
 
 
The Heidelberg Model hypothesizes a relation between this sinusoidal-pattern 
F->74=<1>- 80);-;G )6, <0- ,1..-:-6<1)4 )+<1>1<A 7. <0- )=<76751+ 6-:>7=; ;A;<-5)6, 1<;
major molecular effectors (e.g. hormones, neurotransmitters, etc) (figure 7). 
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Figure 5- Regulation as a sinusoidal curve 
 
 
 
(Greten H. , Understand TCM Scientific Chinese Medicine- The heidelberg Model, 
2010 5th ed)   
In the morning the incubator will be at room temperature. When we switch 
on the system, the electric heater will switch on because the actual temperature 
is below the target value and it will take a while until the temperature rises to 
37ºC.  
Phase I: target temperature is reached and therefore the thermostat turns 
off the electricity to the heater. Nevertheless the temperature will still rise a little 
because the heater is still hot (afterheat) In biological scenario: phase Wood 
Phase II: this excess afterheat is gradually used up, so the water cools 
down back to the target value. After cooling down the target temperature, the 
heater will be turned on again. Phase Fire. 
Phase III: The heater is turned on, but it takes sometime until the heater is 
hot again (latency). Biological scenario; phase Metal 
!
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Figure 4. The Heidelberg Model of TCM establishes a parallelism between TCM concepts 
of disease and physiological processes at four levels of regulation: neurovegetative, 
humorovegetative, neuroimmunological, and cellular level. 
 
The laws of regulation indicate that most of the regulatory processes are based on 
periodic fluctuations of the actual value around a target value of regulation. Applying this 
model of regulation to the vegetative system results in the categorization of symptoms 
leading to the so-called orbs, or organs patterns, of Chinese Medicine. This reveals that 
<0-;-F7:/)6;8)<<-:6;G+)6*-:)<0-:=6,-:;<77,);80A;1747/1+)48)<<-:6;7.>-/-<)<1>-
origin than as organs, thus allowing to translate ancient Chinese physiology in terms of 
western vegetative physiological knowledge [116].  
The technical and regulatory dimension of Yin/Yang and the evolutionary phases (EP), 
i.e., Wood, Fire, Earth, Metal, Water, can be seen in an analogous example of the 
regulation of temperature in a water basin by a thermostat system. Due to the inherent 
fluctuations, the actual temperature value moves around the set point approximately in a 
sinus wave. (figure 5). 
 
 
Figure 5. Regulation as a technical process. The 
temperature profile of the pool is not constant 
(straight line), but rather sinusoidal. Temperature is 
on the y-axis and time plotted on the x-axis, which 
corresponds to the desired temperature.  
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Phase IV: After a while the heater will be warmer than the water, so the 
temperature and the energy content in the basin will be regenerate 
(regeneration). Biological system: phase Water  
And this will go on and on in a repetitive pattern. This sinus wave, from 
another perspective, is a circular movement, and the axis of this movement is the 
target value, the Earth  (black dots on the graphic). 
And this regulation is not only with temperature, it can be extrapolated to 
other body systems for example overall vegetative activity of man. High activity 
will be then yang or repletion; low activity will be yin or depletion. (Here 
interpretation of yin is below target value and yang above target value). 
 
Figure 6- Phases in TCM and western physiology 
 
(Greten H. , Understand TCM Scientific Chinese Medicine- The heidelberg Model, 2010 5th ed) 
 
 The above figure symbolizes in its upper part the clinical 
appearance of the visible signs of the phases- the coppersmith in Wood with 
active extensor muscles, higher blood pressure than the lady in phase metal. 
!
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Figure 7. Postulated 
assignment of phases of 
Chinese medicine into the 
autonomic nervous system with 
respective analogies between 
the phases and the 
neurohormonal mechanisms.  
W E Wood phase. F E Fire 
phase. M E Metal phase. 
 
 
Scientific proof of efficacy based on this model has been reached by a novel double 
and even triple blinded assay of evaluation in acupuncture research. Greten et al. [3] have 
shown that in double or triple blinded study design, acupuncture based on this 
:-+76;<:=+<176 7. +4);;1+)4 <0-7:A 1; )457;< ,7=*4- ); -..-+<1>- ); +=::-6< F?-;<-:6G
acupuncture . Analogue data has been shown for polyneuropathy [117], in congestive 
heart failure[118, 119], pain following sternotomy in heart surgery, respiration after heart 
surgery, pain after tonsillectomy [120], walking distance and peripheral arterial occlusive 
disease [116]. Nevertheless more studies are needed to support this model. 
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(Group of signs-patterns in Chinese medicine). Below the graphic there is a 
schematic reduced form of the concept of transmitters and neuronal pathways-
the western physiological description of a vegetative sinus wave. 
  
  As a scientific proofing this theory, there are a number of studies based on 
this HD model: for pain following tonsillectomy (Sertel, et al., 2009); 
polineuropathy (Schroeder, Liepert, Remppis, & Greten, 2007); congestive heart 
failure (Greten, et al., 2008); walking distance in peripheral occlusive disease 
(Forschungsemeinschaft, 2006), gait improvement(Hauer K, 2011), qi gong 
effects(Sousa, et al., 2012)(Matos, Goncalves, Silva, Mendes, Machado, & Greten, 
2012)	  
2.1Diagnosis	  in	  Heidelberg	  Model	  of	  TCM:  
There are four mechanisms to become sick, according to TCM: 
1- Excess of an agent (see below) 
2- Problems in transition from one phase to the next 
3- Imbalance of antagonist phases 
4- Yin deficiency (less substance- so as in water basin example- less water 
in the basin thus causing higher variations in the temperature 
Figure 7-Four Components of Functional Diagnosis in TCM 
 
(Greten H. , Understand TCM Scientific Chinese Medicine- The heidelberg Model, 2010 5th 
ed) 
	   34	  
 
The figure above shows us a schematic of the TCM diagnosis. 
 
 First: Constitution- Refers to the inner nature, individual functional 
properties- based on the characteristics shown externally (physical pattern, way 
of walking, characteristics of the voice, among others) 
 
Second: Agent- pathogenic factor eliciting specific signs and symptoms by 
changing the individual functional properties (constitution) and/or producing 
symptoms by itself causing orbs patterns. 
 
Table 4- Agents in TCM 
External Agents Ventus (‘wind’), algor (‘cold’), humour 
(‘humidity’), ariditas (‘dryness’), aestus 
(‘summer heat’), ardour (‘glow”) 
Internal Agents Ira (‘anger’), voluptas (‘lust’), cogitatio 
(‘excessive thinking’) maeror (‘grief’), 
solicitudo (‘worriedness’), timor 
(‘anxiety’), pavor (‘shock’)  
Neutral Agents overwork, malnutrition, trauma, 
infections. 
 
  
Third: Orb: “” Group of diagnostically relevant signs and indicate the 
functional state of the body island, which correlates with the functional state of 
the conduit; also a clinical manifestation of a phase named after a region of the 
body”(Greten H. , Understand TCM Scientific Chinese Medicine- The heidelberg 
Model, 2010 5th ed) 
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Figure 8- Phases/Orbs and the principal problem of regulation 
 
(Greten H. , Understand TCM Scientific Chinese Medicine- The heidelberg Model, 
2010 5th ed) 
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Forth part of diagnosis in TCM is Guiding Criteria (GC). There are four GC: 
 
1st GC- repletion/depletion (‘excess/emptiness’) originates from qi, orbs, 
phases in TCM and corresponds to neuro-vegetative signs in western medicine. 
Repletion indicates too much qi or blockage of the flow causing excess in the pre-
blocked area, in general the symptom is worse with pressure, excitation of 
activating mechanisms as opposed to depletion which indicates lack of qi, 
amelioration of the symptoms by pressure and indicates lack of activation and/or 
excess of deactivation) 
2nd GC- calor/algor (‘heat/cold’) in TCM evaluates effects of xue (‘blood’ 
functional capacity bonded to body fluids with functions such as warming, 
moisturizing, creating qi and nourishing a tissue.) and in western medicine refers 
to signs originated from the humoro-vegetative system, referring to the effects of 
microcirculation, therefore increased xue activation-increase in microcirculation is 
called calor, and lack/diminished microcirculation-xue represents algor. 
3rd GC- extima/intima (exterior/interior) evaluates the signs caused by an 
external agent- the most common model is Shan han Lun- Algor laedens theory-
ALT- model of six stages algor- (Figure	   14) describing the pathogenic process 
caused by the agent algor, induced by the neuroimmunological mechanisms. 
Describes the regional lack of microcirculation caused by agent algor as in 
reflexes in common cold such as complement system, prostaglandins (stage I- 
yang major) counter reaction with general increase in the microcirculation, 
inflammatory processes, fever-“reactive calor”) (stage II-splendour yang), as the 
disease progresses development of fever/cold, nausea occurs (stage III – yang 
minor). Until now the agent is in the exterior-conduits extima. When the immune 
systems is weak the agent penetrates the interior-intima causing cough with 
expectoration, (stage IV- yin major) and could worsen to pneumonia (stage V-
yin flectens) generalized weakness and even death, or gradual recovery (stage 
VI-yin minor) 
4th GC- yin/yang evaluates the signs according to TCM to distinguish 
between primary deregulation (yang) and secondary deregulation due to 
structural deficiency (yin). If a functional tissue is deficient, there will be excess 
over regulation to achieve appropriate function, thus leading to exertion of tissue 
function and function deficiency. In western medicine-a deficient tissue can be 
vegetatively over stimulated causing signs of repletion-after the exertion signs of 
depletion will occur-so in this case yin represent deficiency of functional tissue, 
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structural, and/or deficiency of xue (microcirculation), deficiency of body fluids, 
lack/deficit of jing (cell nucleus- gene). And yang – symptoms are more related to 
the functional aspect, not with the structure. 
 
3.Acupuncture	  
Acupuncture’s history is known to go back to China about 2500-3000 
years ago, when there is mention of the first treatment using needles to stimulate 
certain points. But surprisingly, the “Tyrolean Iceman” who lived about 5200 
years ago, has tattoo marks that according to some experts, correspond to 
acupuncture points leading the suggestion that there was therapy similar to 
acupuncture in Europe by this time (Dorfer, et al., 1999), suggesting that 
acupuncture was also applied in western countries long ago. 
 
Figure 9- Example of tattoos on the Tyrolean Iceman 
 
Top, three groups of parallel lines running in longitudinal direction on the left side 
and one group on the right side of the back (arrows). The groups on the lower left back 
and on the right side of the spine are barely visible. Bottom, one of the two tattoo crosses 
found, located above and behind the left, lateral malleolus (arrow). The course of the 
urinary-bladder acupuncture meridian and the location of urinary bladder  
From: The Lancet, vol 354 issue(Dorfer, et al., 1999)with permission 
 
In the beginning needles made of stone were used and nowadays metal 
needles are employed. More recently acupuncture has been incorporated into the 
Traditional Chinese Medicine (TCM). 
The first official description of Chinese Medicine was in the Yellow 
Emperor’s Classic on Internal Medicine (“Huangdi Neijing”) dated 2300 years ago, 
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although it is believed that most of the history of Chinese Medicine dates back 
around 4 to 8 thousand years-lying in the obscure of history.(Greten H. , 2006). 
Nowadays we have a group of related acupuncture techniques and styles such as 
Japanese, Korean, French, Vietnamese and those based on microsystems such as 
auriculoacupuncture, Korean hand acupuncture and cranioacupuncture. 
Acupuncture techniques comprise different procedures such as pressure 
on acupuncture points (acupressure), use of needle insertion, applying heat 
usually with Artemisia (moxibustion) (Porkert M. a., 1995), combined with electric 
stimulus on the needle (electro acupuncture) (Bastos, 1993), use of laser(Litscher 
G. a., 2012). 
It was in the 13th century after the first medical description of the 
acupuncture by a western physician-William of Rubruck (Bivens, 2000) that the 
interest in acupuncture appeared and many publications emerged. But the 
interest in this field fluctuated until 1971, when a US journalist James Reston 
published in the New York Times that he had received a successful acupuncture 
treatment after an appendectomy while he was in China- (Reston, 1971). Since 
this publication in the media, the general interest from lay people has been 
increasing and many others papers surged. So, in 1997 a ‘ consensus conference’ 
by National Institute of Health supported that acupuncture could be useful in an 
array of conditions such as post-operative and chemo nausea and vomiting, 
dental pain, fibromyalgia among others.(National Institute of Health, 1997). 
Additionally in 2003, the World Health Organization review stated that 
acupuncture has been proved for at least 28 medical conditions.(WHO, 2003) 
In eastern medicine it is the functional state that is considered, whereas in 
western medicine it is based on the matter, substratum and expresses their data 
based on the metric system(Porkert, 1983), therefore it is important to 
understand the following points in order to comprehend the concepts behind 
acupuncture: qi, yin/yang, and Five Elements. 
Qi (pronounced "chee") is an Immaterial energy with a qualification and direction 
(Porkert M. , 1974) and  “vegetative capacity to function of a tissue or organ 
which may cause the sensation of pressure, tearing or flow, according to the 
Heidelberg (HD) Model of TCM –described above). Diseases are believed to be 
associated with an imbalance deficiency, blockages, causing excess of qi. 
Yin and yang are terms used to describe all things in nature and are 
complementary opposites. Yin is used to represent more material, dense states of 
matter while yang is functional, represents more immaterial, rarefied states of 
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matter. And the interaction between the two opposites is dynamic and cyclical. To 
the acupuncturist, health is a constant state of dynamic balance and one must 
employ a series of qualitative assessments to establish a patient's present 
disposition(Maciocia, 1989). 
According again to Maciocia, 1989, the Five Elements are wood, water, fire, 
earth, and metal, interacting to each other. They represent not only the basic 
constituents of nature, but also represent different basic processes, qualities, or 
phases of a cycle. Most vital organs, acupuncture meridians or conduits, 
emotions, and other health-related variable are assigned an element, thus 
providing a global description of the balancing dynamics seen in each person.  
The Chinese Medicine practitioner uses these principles for diagnosis and 
treatment selection. After determining the imbalance, the objective is to shift the 
constitution towards balance with the use of some resources. Acupuncture is one 
important among them. Eastern medicine values the clinician's initial assessment 
and encourages the practitioner to value his/her own intuition to extract 
additional information. Eastern thought perceives the world as dynamic and 
interconnected (Capra, 2000 4th ed)]. Thus it makes little sense to the 
acupuncturist to isolate a symptom such as back pain. Symptoms necessarily 
arise from a particular context. Acupuncture treatments are therefore usually 
individualized, and two patients with the same symptoms often do not get the 
same treatment, furthermore as this is a dynamic process even the same patient 
may also not receive the same treatment on every following visit. 
The technique of needle insertion depends on the therapeutic effects 
desired, and on the quality of stimulation intended (dispulsion in repletion or 
suppletion in depletion), topology of the site, direction of the conduit.(Porkert M. 
a., 1995) 
  
3.1	  Electro	  acupuncture	  
 
Electro acupuncture (EA) is a technique that stimulates the needles with a 
small electrical current at low frequency (2 to 4 Hz) or high frequencies (100-
200Hz) and it seems to be one strong form of acupuncture.(Ulett, 2002) and can 
induce long clinical response in rats during 1 to 12h(Yao & Anderson, 1982). 
In experimental protocols, EA could be preferred to manual acupuncture , 
when possible, because with EA it is possible to keep a steady stimulation of a 
period of time that could be measured and is reproducible.(Ulett, 2002) 
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Comparison of Manual acupuncture (MA) and EA using low-frequency 
stimulation (~2 Hz) applied for 120 seconds every 10 minutes over a 30-minute 
period found similar effects on the increase in blood pressure cardiovascular 
reflex response to gastric distension (pressor stimulus) in anesthetized rats. The 
only difference in response was a slightly more prolonged effect of EA (effect 
duration of 30min) as compared to MA (2min every 10min) effect that lasted 20 
min after termination of stimulation. Both forms of stimulation caused nearly 
identical responses of afferent single units recorded in the median nerve.(Zhou, 
Fu, & Tjen-Looi, Afferent mechanisms underlying stimulation modality -related 
modulation of acupuncture-related cardiovascular responses, 2005) Also Zhou et 
al in 2005 observed that sympathoexcitatory sympathetic premotor neurons in 
the rostral ventral lateral medulla (rVLM) were found to respond similarly to MA 
and EA, specifically the low current (2mA) and low frequency (2Hz) and not high-
frequency EA (40-100Hz). This study raised considerable question about the 
ability of high-frequency EA to provide afferent input to the CNS to regulate 
sympathetic outflow (Zhou, Tjen-A-Looi, & Longhurst, 2005) 
Another studies with both low and high frequency electro acupuncture can 
modulate sympathetic motor changes in pain (Ernst & Lee, 1985). 
EA at different frequencies causes diverse cardiovascular responses, thus 
low-frequency (2Hz) causes depressor response (Lee H. a., 1994) whereas High 
frequent EA can cause pressor response in normal individual(Ernst & Lee, 1985).  
 
 
3.2.Acupuncture	  and	  	  Cardiovascular	  System	  
 
 According to the consensus on Complementary and Investigative Medicine 
published by the American College of Cardiology in its task force(Vogel, 2005), 
acupuncture could be indicated in four areas in cardiovascular diseases (CVD): 
Ischemic CVD, hypertension, heart failure (HF), arrhythmias.  
The World Health Organization (WHO, 2003)reviewing acupuncture in more 
than 40 medical conditions, found that acupuncture is effective in hypertension 
and some coronary heart disease. 
The sympathetic activation in the cardio vascular system leads to an 
increase in heart rate (HR), BP, myocardial contractility an/or myocardial oxygen 
demand during a pressor stimulus. Therefore the use of acupuncture for these 
areas of CVD is justified by its ability to inhibit the sympathetic outflow(Yao & 
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Anderson, 1982), and therefore the cardiovascular sympathoexcitatory effect 
reflex(Zhou & Longhurst, Neuroendocrine mechanisms of Acupuncture in the 
Treatment of Hypertension, 2012)(Zhou, Fu, & Tjen-Looi, Afferent mechanisms 
underlying stimulation modality -related modulation of acupuncture-related 
cardiovascular responses, 2005) And it could be probably due to the following 
pathway (Middlekauf, et al., 2002): 
  	  
Figure 10- Probable pathway for acupuncture action in CVD 
 
The cardiovascular system is integrated, therefore action in BP could also 
have effects in CHD, treatment for arrhythmias also could have results to 
decrease oxygen demand and relieve discomfort from CHD, peripheral resistance 
works not only to reduce the BP but also to decrease the cardiac workload 
therefore also reduce myocardial ischemia.  
 
3.2.1	  Acupuncture	  and	  coronary	  heart	  disease	  
	  
Some experimental studies in cats demonstrated reduction in myocardial 
ischemia by reducing oxygen demand instead of increase in coronary flow(Li, 
Pitsillides, Rendig, Pan, & Longhurst, 1998). Another study in chinchilla rabbit 
showed improvement in acute myocardial ischemia after electro 
acupuncture.(Cai, et al., 2010). Also there seems to be a cardio protection of 
reperfusion injury by modulation of norepinephrine release, apparently via 
Acupuncture	   Increase	  sensory	  afferent	  activity	  
Increase	  the	  release	  of	  opioid	  by	  CNS	  
Decrease	  Efferent	  Sympathetic	  nerve	  activity	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inhibition of cardiac nervous system in an opioid and protein kinase C dependent 
pathway.(Zhou, et al., 2012) 
Richter and colleagues, in a placebo controlled, cross over study design 
(Richter, Herlitz, & Hjalmarson, 1991) showed that manual acupuncture reduced 
in episodes of chest pain and its magnitude and improvement in ST depression 
and increase in work load to elicit chest pain as assessed by exercise test. Also 
improvement in exercise test was observed in other studies(Ballegaard, Jensen, 
Pedersen, & Nissen, 1986)(Ballegaard, Pedersen, Pietersen, Nissen, & Olsen, 
1990). 
In a study using acupuncture in Pc6 (neiguan), Kurono et al(Kurono, Egawa, 
Yano, & Shimono, 2002) showed a vasodilatation in coronary arteries in some 
patients with coronary stenosis, but no vasospastic or syndrome X, without 
inducing systemic hypotension. 
Those studies were either experimental or with a small group of patients 
and larger well-designed studies are granted in this subject. 
 
3.2.2	  Acupuncture	  and	  Heart	  Failure	  	  
         A clinical pilot study by Middlekauff et al. ((Middlekauf, et al., 2002) with 
fifteen advanced heart failure patients that underwent acute mental stress testing 
before and during a single session of real acupuncture demonstrated surges in 
sympathetic activation during mental stress (a potent stimulus to the autonomic 
nervous system) were eliminated by acupuncture. As the patients were submitted 
to only one session of acupuncture, these findings cannot be extrapolated to the 
normal average 10 sessions acupuncture performed in clinical practice. The 
authors concluded that acute acupuncture attenuates adrenergic excitation 
during mental stress in advanced heart failure patients. 
 Kristen et al(Kristen, et al., 2010) in a pilot study observed that an increase 
in exercise tolerance by patients with heart failure as assessed by ambulated 6-
minute walk distance after acupuncture. 
 Heart rate variability is a prognostic indicator in heart failure(Ponikowski, 
1997) and some studies has been carried showing the effects of acupuncture on 
it(Huang, Chen, Lo, Lin, Lee, & Kuo, 2005; Bobkova, Gaponiuk, Korovkina, 
Sherkovina, & Leonova, 1991; Bobkova, Gaponiuk, Korovkina, Sherkovina, & 
Leonova, 1991) (Litscher G. , 2007)(Hsu, Liu, Tsai, & Chang, 2006)(Kristen, et al., 
2010). 
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3.2.3	  Acupuncture	  in	  arrhythmias	  	  
 Acupuncture can inhibit ventricular premature beating (extra systoles) by 
stimulating the hypothalamus, paraventricular nucleus(Guo, Jai, Cao, Guo, & Li, 
1981) or after administration of BaCl2(Li & Yao, Mechanism of the Modulatoty 
Effect of Acupuncture on Abnormal Cardiovascular Functions, 1992). 
 Here again the rationale for its application sits on the ability to inhibit the 
sympathetic outflow.(Yao & Anderson, 1982). 
 In anesthetized rabbits the number of ventricular extra systoles induced by 
stimulus in hypothalamus was reduced by electro acupuncture in S36 and Pc6 
acupoints, whereas stimulation of superficial peroneal and superficial radial 
nerves elicited excitatory responses. Further experiments showed that this 
inhibitory action of S36 and Pc6 was due to inhibition of the cardiac sympathetic 
centre in rVLM, and acts through opioid, GABA and 5-HT receptors in this region. 
Conversely the excitatory response may be related to activation of cholinergic 
response in the same rVLM(Li & Yao, Mechanism of the Modulatoty Effect of 
Acupuncture on Abnormal Cardiovascular Functions, 1992)(Guo X. L., 1986). 
 As for bradicardia, EA applied to superficial peroneal nerve or superficial 
radial nerve produced partial blockage of the bradicardia provoked by stimulus in 
the aortic nerve or nucleus tractus solitary. Also stimulus with high current in 
deep peroneal or median nerve blocked this bradicardia. It was demonstrated 
that activation of cholinergic receptors in rVLM contributes to suppress vagal 
evoked bradicardia. This activation in rVLM inhibits both baroceptor sensitive 
neurons in the dorsal vagal nucleus and nucleus ambigus. GABAergic and opioids 
may play important role in mediation of this reflex inhibition.(Li & Yao, 
Mechanism of the Modulatoty Effect of Acupuncture on Abnormal Cardiovascular 
Functions, 1992)(Wang, Guo, & Li, The inhibitory effect of somatic imputs on the 
excitatory resposes of vagal cardiomotor neurones to stimulation of the nucleus 
tractus solitarius in rabbits, 1988)(Wang & Li, A GABAergic mechanism in the 
inhibition of cardiac vagal reflexes, 1988)  
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3.2.4	  Acupuncture	  and	  Hypertension	  
 
Acupuncture can have an antihypertensive through a milieu of ways, levels 
and factors, balancing and integrating the cardiovascular system, nervous 
system, endocrine and hormone regulation.(Zhang R. H., 2007) 
There are publications in China as early as in the 50’s, pointing the 
success in lowering the BP(Zhang C. , 1956), since then, there have been many 
studies of the effects of acupuncture in the hypertension.  
 
The central nervous system plays an important role in the development 
and maintenance of hypertension. Increased sympathetic activity and alteration in 
arterial baroreflex function may contribute to the development of hypertension. 
(Veerasingham & Raizada, 2003)          
An augmented sympathetic tone leads to an arteriolar vasoconstriction and 
by increasing the force and rate of contraction of the heart to increase cardiac 
output. As BP=CO X RP, here, there is an important direct action of increased 
sympathetic activity on hypertension. Also increased renal sympathetic activity 
leads to an increase in production of Renin. Renin activates the conversion of 
angiotensinogen into angiotensin I. The ACE converts angiotensin I in angiotensin 
II, which can cause vasoconstriction (rise in peripheral resistance) per si, and also 
stimulate aldosterone, causing salt retention, both mechanism that contributes to 
the elevation of the blood pressure.(Zhou & Longhurst, Neuroendocrine 
mechanisms of Acupuncture in the Treatment of Hypertension, 2012) 
Carotid sinus and aortic arch baroceptors acts modulating parasympathetic 
and sympathetic outflow in response to changes in BP. Nevertheless an elevated 
blood pressure with time leads to a resetting of the baroceptors to a higher 
pressure, contributing to the perpetuation of hypertension. 
In hypertensive animal model there are changes in CNS, mainly in 
hypothalamic and medullar areas that modulate sympathetic flow.(Colombari, 
Sato, Bergamaschi, Campos, & Lopes, 2001). Angiotensin II apart from its direct 
action in vasoconstriction, indirect action via aldosterone also acts at various 
hypothalamic and medullar areas to enhance sympathetic outflow, alters the 
sensitivity of baroceptors and stimulates secretion of vasopressin.(Averill & Diz, 
2000)(Dampney, Fontes, Hirooka, Horiuchi, Potts, & Tagawa, 2002) 
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Figure 11 Neural circuits of acupuncture's action in reflex blood pressure 
modulation 
 
Neural circuits of acupuncture's action on cardiovascular 
sympathoexcitatory visceral reflex elevation of blood pressure. Abbreviations: 
ARC: arcuate nucleus; vlPAG: ventrolateral periaqueductal gray; NR: nuclei raphe; 
rVLM: rostral ventrolateral medulla. 
From:Evid Based Complement Alternat Med. 2012; 2012: 878673.  
 
EA	  in	  the	  rVLM	  	  
 The rVLM plays a critical role in the control of BP and inhibition of the 
functions in this nucleus decreases significantly the BP.(Guertzenstein, 1974)In 
fact, EA inhibited the elevation of BP and sympathetic neural activity in the rVLM 
following gastric distension (pressor stimulus) in rats. (Zhou, Tjen-A-Looi, & 
Longhurst, 2005).  
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This nucleus and its premotor sympathetic neuron seem to be very 
responsive to deep nerves stimuli (median- Pc6 in acupuncture, radial-IC11 as 
acupoint) (Tjen-A-Looi, Li, & Longhurst, Medullary substrate and differencial 
cardiovascular responses during stimulation of specific acupoints, 2004). The EA 
action is inhibited by a non-specific opioid antagonist (naloxone) and also by a 
GABA blocker suggesting at least part of the action of this intervention is via 
opioid (ß endorphin, endomorphin and enkephalin but not dynorphin) and 
GABA(Tjen-A-Looi, Prolonged inhibition of rostral ventral lateral medullary 
premotor sympathetic neurons by electroacupuncture in cats, 2003) Also 
nocioceptin and serotonin seem to be involved. (Han J. , 2004).  
Different frequencies of EA stimulate different somatic fibers: Low 
frequency EA (2-4Hz) activates  µ ∂ receptors releasing endomorphin, encephalin, 
ßendorphin and lowering the pressure while high frequency 200Hz stimulate k 
receptor and releases dynorphin (a potent analgesic).(Han J. S., 2003)(Han J. , 
2004) Chao et al(Chao, Shen, Tjen-A-Looi, Pitsillides, Li, & Longhurst, 
1999)showed reversal of the sympathetic response to EA after naloxone, but only 
after those elicited by low frequency (4Hz) and not those induced by high 
frequency (200Hz). EA seems to act also by reducing the plasma serotonin and 
norepinephrine. (Zhou, et al., 1995). 
The point specificity in lowering the BP has been shown in a study where 
they used negative and positive electrodes in adjacent points observed that 
stimulus in Pc5-Pc6, IC10-IC11, IC4 -IC7 and S36-S37 effectively lowered BP 
whereas IC6-IC7 and S37-S39 did not. (Tjen-A-Looi, Li, & Longhurst, Medullary 
substrate and differencial cardiovascular responses during stimulation of specific 
acupoints, 2004). 
Important centres in sympathetic tone control: 
-­‐ Hypothalamus arcuate nucleus (central) and is an important source 
of opiates that are transported to regions such as rVLM(Guo & 
Longhurst, 2007), and also stimulates the vlPAG(Li, Tjen-A-Looi, & 
Longhurst, Excitatory projections from arcuate nucleus to 
ventrolateral periarqueductal gray in electroacupuncture inhibition 
of cardiovascular reflexes, 2006) 
-­‐ vlPAG (midbrain) is a cardio depressor region- send directly or 
indirectly inhibitory inputs to rVLM reducing sympathetic flow and 
thus inhibiting the elevation in BP to a pressor stimulus(Tjen-A-Looi, 
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Li, & Longhurst, Midbrain vlPAG inhibitis rVLM cardiovascular 
sympatoexcitatory responses during electroacupuncture, 2006) 
-­‐  NRP-medullar nucleus raphé pallidus –receives projections from 
vlPAG and may act through serotonin receptors in the rVLM acting 
in modulation of cardiovascular activity 
-­‐ rVLM (see above) 
EA can act directly or indirectly in these centres thus modulating the 
cardiovascular responses.(Zhou & Longhurst, Neuroendocrine mechanisms of 
Acupuncture in the Treatment of Hypertension, 2012) 
 
Figure 12 Neuroendocrine modulation of Blood Pressure by acupuncture 
 
GABA γ-aminobutiric acid; 5HT-5-hydroxytryptamine or serotonin; NO:nitric oxide, 
IML:intermediolateral column of the spinal cord 
From: Evid Based Complement Alternat Med. 2012; 2012: 878673. 
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In stress-induced hypertension in rats, stimulation of the deep peroneal 
nerve (DPN) underneath the Zusanli (S36) acupoint with a low current and low 
frequency for 10 min reduced BP markedly with a nadir occurring 1 h later. 
Microinjection of naloxone into the rostral ventrolateral medulla (rVLM) blocked 
this depressor effect, suggesting that this depressor effect is related to the 
activation of opiate receptors in this region of the medulla.(Xie, 1997)   
In anesthetized open-chest dogs, EA in acupoint Neiguan (PC6) provided a 
stable cardiovascular function under normotension and an anti-shock effect on 
haemorrhage-induced hypotension, whereas in conscious dogs EA applied to 
Zusanli (S36) with a current of 2-4 V, 1-100 Hz had no significant effect in 
normotensive dogs. However, after continuous endovenous noradrenalin 
administration at a constant rate and raising of systolic blood pressure to 178/20 
mm Hg (a level that could be kept for more than 1 h) EA was then applied to 
Zusanli or Neiguan acupoints for 20-30 min and a decrease of blood pressure (BP) 
by 20-30 mm Hg, a statistically significant effect compared to the basal BP before 
EA or control group (P < 0.01). BP was maintained at low level during EA and 
returned slowly to the pre-EA high-level 30-40 min after EA was terminated. This 
inhibitory effect of EA was not found in anesthetized dogs. Further analysis 
showed that the depressor effect of EA is mainly caused by vasodilatation of 
mesenteric vessels and due to inhibition of sympathetic vasoconstrictor tone. 
Experiments also showed that the depressor effect of EA in this kind of 
hypertension was due to the inhibition of arterial chemoreceptor pressor reflexes, 
but not to the activation of the baroreceptor reflexes. The central inhibition of EA 
was related to the activation of opiate receptors in the periaqueduct gray (PAG), 
hypothalamic supramammillary area and the dorsal hippocampus. (Syuu, et al., 
2001)	  
Activation of eNOS (endothelial nitric oxide synthase) and nNOS (neuronal 
nitric oxide synthase) is one of the mechanisms through which ST- 36 electro 
acupuncture reduces blood pressure, as observed by Kim et al. with a model two-
kidney, one-clip renal hypertension (2K1C) hamster model, submitted to thirty-
minute daily electro acupuncture treatment for 5 days leading to a reduction in 
mean arterial pressure from 160.0 ± 7.6 to 128.0 ± 4.3 mmHg (mean ± SEM), 
compared to 115.0 ± 7.2 mmHg in sham-operated hamsters, confirming the 
hypothesis that acupuncture on acupoint stomach 36 point (S36) reduces 
hypertension by activating nitric oxide synthase signalling mechanisms.  (Kim, et 
al., 2009)         
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Using awaken adult spontaneous hypertension rats (SHRs) and their 
normotensive controls, Winstar-Kyoto rats (WKY), after stimulation of the sciatic 
nerve with low frequency and low current for 30 min to mimic EA, BP was 
decreased 20 mm Hg below the pre-stimulation level, and did not fully recover to 
its high pre-stimulation level until 12 h after the termination of sciatic nerve 
stimulation. The HR and splanchnic sympathetic discharge outflow decreased in 
parallel with BP. WKY rats revealed no significant response of BP and HR following 
sciatic nerve stimulation. The long-lasting post-stimulation depressor response 
was unchanged by sino-aortic nerve transection. They reported the use of a 75 
current for the stimulation of the sciatic nerve to elicit a depressor effect that was 
above the threshold for activating group III fibers. Further study showed that 
endorphins and serotonin were involved in the post-stimulation depressor 
response. (Yao & Anderson, 1982) 
As increased renal sympathetic activity leads to an increase in production 
of Renin, thus another mechanism that can explain the effects of acupuncture in 
hypertension is via decrease in the plasma renin, aldosterone and angiotensin II 
activity (Anshelevich, Merson, & Afanas'eva, 1985)(Huang H. a., 1992)(Chiu, Chi, 
& Reid, 1997) and this has a similar action of ACEi. In fact, lower angiotensin I 
levels were found in hypertensive patients who received acupuncture when 
compared to a control group of hypertensive patients who did not receive 
acupuncture (Chiu, Chi, & Reid, 1997). Increased excretion of sodium also was 
observed following acupuncture.(Yao T. , 1993) 
Acupuncture can modulate the neurohumoral system as seen on reduced 
plasmatic norepinephrine, serotonin and endorphin levels after this 
procedure.(Middlekauf H. Y., 2001)(Zhou, et al., 1995) 
Influence on secretion of the endothelium, regulating the balance between 
contraction factors (EDCF-endothelium derived contraction factors) and relaxation 
(EDRF Endothelium Derived Relaxation Factor) also seems to play a role in the 
usage of acupuncture to treat hypertension (Zhang R. H., 2007) 
A review of literature reveals various reports showing the effectiveness of 
acupuncture on blood pressure and other hemodynamic parameters in 
humans(Flachskampf, et al., 2007) (Yin Z. , 1998)(Anshelevich, Merson, & 
Afanas'eva, 1985; Kearney, Whelton, Reynolds, Muntner, Whelton, & He, 
2005)(Huang H. a., 1992)(Bobkova, Gaponiuk, Korovkina, Sherkovina, & Leonova, 
1991)(Dovgiallo, 1987) (Williams, 1991)(Tam, 1975)(Radzievsky, Lebedeva, 
Fisenko, & Majskaja, 1989)(Monaenkov, 1984)(Akhmedov, 1993)(Dong, 1996) , 
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but only a few of them controlled, specially in western community.(Macklin, et al., 
2006)(Lee, Kim, Park, Kim, Lee, & Park, 2009) 
The SHARP (Stop Hypertension with the Acupuncture Research Program) 
pilot study, randomized, controlled, although not designed to detect small effect, 
is a large study on acupuncture for hypertension. The authors concluded that 
active acupuncture provided no greater benefit than invasive sham acupuncture 
in reducing systolic or diastolic BP, (Macklin, et al., 2006), but the analysis were 
done considering just the BP measurement in the office visits, not measuring the 
24 ABPM, therefore it haven’t measured the BP reducing effects through a larger 
period in daily life, thus some other factors such as white coat hypertension 
could be influencing the results. Moreover this method can ‘measure more 
accurately than clinic BP the extent of BP reduction induced by treatment’ 
(ESH/ESC, 2007) 
Nevertheless, in a more recent, well designed study, Flachskampft et al. 
randomized 160 patients, 140 finishing the treatment and found a significant 
difference in the decrease in 24 hour SBP by 6,4mmHg and 3,7mmHg DBP. 
(Flachskampf, et al., 2007). 
Also in a well-designed double-blinded, randomized, controlled trial a 
significant long-term antihypertensive effect of acupuncture was reported. It was 
shown a BP declines of 14.8/6.9 mmHg in their active acupuncture group (n=15) 
versus 4.0/1.1 mm Hg in the sham group (n=15; p=0.05) after 16 sessions -8 
weeks of twice-weekly treatments.(Yin, et al., 2007)  
 In addition, a recent study (Kim, et al., 2012) a decrease in the nocturnal 
diastolic dipping was significantly different between active and sham acupuncture 
group, suggesting that this treatment could be useful to improve the circadian 
rhythm of BP in patients with hypertension. 
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4.	  Hypertension	  in	  TCM	  view	  
 
The Chinese Medicine focus on a deeper level of the concrete disease and 
individually, instead of in the syndrome conception.(Zhang R. H., 2007) 
After 35 years of age, there is a great deficiency of structure (yin), which 
potentiates an excess of the activity of the functions of the body (repletion), due 
to a greater lability of the vegetative functional capacity (Qi). Therefore the 
hypertension is a result of the yin/yang  (structure/function) imbalance and also 
an imbalance between hepatic and renal (potential-regeneration)(Zhang R. H., 
2007)(Nghi & Recours-Nguyen, 2010) 
The main pathologic alteration of hypertension is in the hepatic orb 
(functional potential dysfunction) .The structure of the potential activity (hepatic 
yin) is always in deficiency in the hypertension. The vegetative capacity of 
functional potential and activity for induction of this potential (hepatic qi and 
hepatic yang) are always in excess(Zhang R. H., 2007)(Greten H. , Understand 
TCM Scientific Chinese Medicine- The heidelberg Model, 2010 5th ed) 
The relation of the hypertension with the hepatic yin and hepatic yang has 
been studied in many fields such as in endogenous vasoactive substances, 
plasma polypeptides, immunological factors, sensitivity to sodium, insulin 
resistance, blood pressure dynamics, blood pressure variability, cardiac 
remodelling and cardiac function.(Zhang R. H., 2007) 
 
 
4.1	  Acupuncture	  for	  the	  treatment	  of	  Hypertension/	  TCM	  view:	  	  
The pathomechanism according to TCM are: ventus, calor, humor/pituita, 
yin deficiency and stasis.(Zhang R. H., 2007) 
There are many efficient methods to treat hypertension, such as “cleaning” 
the hepatic orb and dispels Ventus (as an external agent-phase wood), support 
the hepatic and renal yin deficiency, eliminate calor and promote diuresis, 
however the main thing of the therapy, according to many clinical reports is “to 
calm down the hepatic orb, suppressing the yang” (suppressing the increased 
sympathetic system) 
The points were selected in order to: 
-support the yin ( corporal substance) 
-promote the regeneration of the damaged end organ 
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-promote sedation and repletion of the hepatic yang ( negative feedback of 
the primary functional problem and excess activity  of the hepatic function) 
-support the orthopathy – (eu-fuction) 
- comproved action in previous studies 
 
4.1.1	  The	  theory	  of	  acupoints	  or	  how	  to	  choose	  an	  acupoint:	  
4.1.1.1	  Theory	  1:	  Conduits	  
Conduits are a line connecting acupoints with a similar effects. 
4.1.1.2	  Theory	  2:	  The	  theory	  of	  the	  five	  inductories	  (or	  five	  antiques)	  
In old China, conduit was illustrated as being similar to a river running 
from the nails to the body. 
So it explains the flow dynamics of qi -valid for internal, yin orbs (see 
below). 
1. First point-distal point close to the nail bed is Puteal-      
  This point is equivalent to a main tap, activating the orb in an 
ON/OFF fashion, used in drastic situation like a collapse, breaking down 
when it is used in a suppletive manner or in a dispulsive manner in uprising 
yang such as hypertensive crisis. 
Associated with phase wood 
2. Second point: pressure relieving valve –effusory 
This point is used in acute repletion or acute calor, diminish the 
excessive potential, so the phase is fire 
3. Third point: point for fine regulation of the already established flow, FINE 
TUNNING of the flow. (point of original qi)-inductory induce an influx in the 
orb (suppletive) or an outflow-to relieve the excess in the interior, in order 
to regulate the interior and exterior qi. Due to these regulating 
characteristics to eu-function this point is phase earth. 
4. Fourth point: compared to a pump to transport the qi furthermore along the 
conduit-transitory, normally used when an agent blocks the flow of qi in the 
conduit. Distribution the qi is function of metal. 
5. Fifth point- conjunctory-is the place where energies goes to the yin. Used to 
strengthen the yin in many chronic diseases, regenerating-so associated to 
water 
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Those phases allocations described above are for the internal, horreal or 
yin orbs because the qi is primary built up in the yin conduits and stored in the 
external (aulic or yang) conduits. 
 
4.1.1.3	  Theory	  3:	  coupled	  conduits	  and	  coupled	  effects.	  
	  
This theory says that the internal and external conduits of a phase are 
coupled- dispulsion in one side, results in suppletion at the respective point in 
the other side. The internal e external orbs are: 
 
Table 5- Phase-Internal and External Orbs 
Phase Internal(horreal, yin) orb External (yang,aulic) orb 
Wood Hepatic Felleal 
Fire Cardial, Pericardial Tenuintestinal,Tricaloric 
Earth Lienal Stomach 
Metal Pulmonar Crassintesinal 
Water Renal Vesical 
 
So according to this theory we have (Figure	  13) 
 The puteal in the internal orbs is wood; in the external they are metal, 
because metal controls wood. 
The effusory in internal orbs is fire; in the external orbs they are water, as 
counteracting to fire 
The inductory is earth in the internal orbs, in the external they are wood 
to balance the effect on the other side, and also because it is often used in a 
suppletive way to enhance energies in the extima. 
The transitory in the yin orbs is metal, so in the external it is fire to 
express the counter balancing effect on internal transitory 
The conjunctory is water on the internal orbs, whereas in external it is 
earth to express the counterbalancing effect on the internal conjunctory.  
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Figure 13-Coupled conduits and allocated phases 
      
(Greten H. , Understand TCM Scientific Chinese Medicine- The heidelberg Model, 2010 5th ed) 
 
 
4.1.1.4	  Theory	  4:	  Algor	  Laedens	  Theory	  (ALT)	  or	  Shan	  Han	  Lun	  (Figure	  14)	  	  
“The stages of the ALT are featured by specific clinical signs, the 
understanding of which is an absolute must for the professional practitioner of 
TCM” (Greten H. , Understand TCM Scientific Chinese Medicine- The heidelberg 
Model, 2010 5th ed) 
There are six layers of energy constituting six stages of defence: 
 
I layer- defensive qi (wei qi)- it is distributed in the extima, outside the 
conduits, and it is the first layer of defence against agents. As algor is a lack of 
microcirculation in western terms, or as a de-activation of xue in eastern terms, it 
may affect those conduits first, which contain more xue than qi.  
The vesical conduit is affected which distributes xue in a segmental fashion over 
the body. 
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Xue is controlled and moved by the cardiac orb. The corresponding 
exterior orb is the tenuintestinal orb and is therefore prone to be affected by 
algor as an exterior agent. 
Thus we have the Stage I (yang major or taiyang) and the orbs affected 
are Vesical and Tenuintestinal. And the main symptoms are: cold shivering, 
goose bumps, and in the hypertension settings we could have pain in the neck, 
stiff neck, headache, pressure between the eyes. 
 
II layer- conduit qi- it is the qi inside the conduits (cardinal qi). When an 
agent blocks the flow of qi, this firstly originates pain and secondary functional 
disorders in the respective orb. 
 When the agent algor enters the conduits, this leads to a regional block of 
flow of qi and xue. Qi flow is blocked more easily than the flow of xue as “qi 
moves the xue”. This is why phases and orbs are more prone to this affection if 
they depend more on qi. The stomachal and crassintestinal conduits depend 
more on qi. 
“All depletion is a depletion of the Centre” is an old rule of TCM indicating 
that the Centre is especially prone to a lack of qi. The external conduit of Earth, 
the stomach conduit, is therefore most easily affected in this stage. 
Depletion, as seen in the sinus wave, may lead to signs of the phase Metal, 
as this phase is depletive in nature and directed downward. This is why the 
external conduit of this phase, the crass intestinal conduit, is also easily affected 
in this stage.  
So this is Stage II (splendour yang or yangming). Here, as agent blocks 
the conduit qi, the microcirculation is activated in order to expel the agent – 
reactive calor 
The main symptoms are: tearing pain as seen in sinusitis, in the 
hypertension context: swellings of the face, impaired, unclear vision, weakness 
and pain in thigh and knee, pain in the neck, shoulder and forearm. 
 
III layer- conduit xue- qi in the conduit moves the xue so the warming, 
moisture and nutrients reach the tissues. 
Xue and qi derive from the interior and are led through the system of 
conduits. If the agent algor overcomes xue flow within the conduit, this may lead 
to a reverse xue flow into the interior. Also algor reaches the interior, causing the 
sensation of inner cold. 
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Often, xue from the inside (the yin) will be mobilised against the agent 
causing the sensation of internal heat again, or, if the agent algor is driven out, 
even temporary heat of the exterior, i.e. the skin (extima). Literally, it is said that 
the agent and xue flow within the conduit play “Tom and Jerry”, driving each 
other in and out repeatedly.  
Mobilisation of internal heat is a feature of the phase Wood (mobilisation 
of potential), and, as this is still an extimal stage, leads to affection the felleal 
conduit.  
Also, this causes symptoms and signs of “imbalanced distribution” of 
energies, which is a principal affection of the tricaloric orb. 
Thus affection of this defence line leads to Stage III (yang minor or 
shaoyang). 
The symptoms usually are: inability to lie on one side of the body, nausea, 
discomfort (”nagging”). Also: hemicranalgia, loss of hearing, tinnitus, tear pain of 
the eyes, pain in the neck, on the chest. 
 
IV layer- Body island qi- qi within the whole body’s interior (intima ) where 
the functions of the orbs are generated in their respective parts of the body 
(“island”-organs residing more or less in the same region) 
All interior affections tend to start with a functional disturbance, so the 
body islands of the orbs are firstly affected in their function (qi). 
When an agent affects qi of the body islands, the lienal and the pulmonary 
orb are more often affected, as the Centre and Metal are sensitive to diminished 
activity of qi.  
Affection in this layer is called: Stage IV (yin major or taiyin) . 
The symptoms are: bronchitis, cough, mucus but could also be 
accumulation of humor and pituita, aggravation of metabolic disorders, swellings 
of all kinds. 
 
V layer- Body island xue: that is the substance (yin) part of the body 
island that warms, functionally activates and enhances properties 
When algor affects xue within the interior, orb functions depending on xue 
are more easily affected than others.   
 As the hepatic orb is considered to be the mare xue (“sea of blood”), 
hepatic orb functions may be impaired. Also pericardiac signs may appear. 
Affection here leads to Stage V (yin flectens or jueyin) 
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Symptoms such as in pneumonia (muscular weakness, undecidedness and 
demotivation, inability to stand up and also symptoms of the chest, heavy 
breathing, palpitations, lack of drive. 
 
VI layer- Yin-  functional tissue- subpopulation of cells from which the 
function (yang) develop 
The renal orb depends on the yin, and the cardiac orb is the yin side of xue 
(the yang side of xue is the pericardiac orb). 
As yang arises from the yin (in the language of the fourth Guiding 
Criterion), an analogue process in the technical terms of the first Guiding 
Criterion is the development of yang qi upwards which is in a rapport with the 
cardiac qi. This connection is also expressed by the terms of a reno-cardiac axis, 
the yin pole of which is the renal orb and the yang pole is the cardiac orb. 
When the yin is affected we have: Stage VI (yin minor or shaoyin). 
The symptoms usually are: lack of power in the knees and in the back, 
inability to get up, reduction of mind will, tendency to timor (anxiety), problems 
of memory, prolonged regeneration, reconvalescence and can also have loss of 
consciousness, fainting, circulatory problems of all kinds, problems also in short-
time memory, problems with mental presence, with heart rhythm, pain in the 
chest, loss of eye sight, hearing and sensory vigilance 
The stages, orbs related, clinical signs, stage hopping can be seen in the 
chart below: 
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Figure 14- Algor Laedens Theory- Shan han lun 
“ALT”	  	  
algor	  laedens	  	  	  	  	  	  	  	  
theory	   Stage	  1=	  Yang	  major	  taiyang	   Stage	  	  2=	  Splendor	  yang	  yangming	  
	  
Stage	  3=	  
Yang	  minor	  
shaoyang	  
	  
Stage	  4=	  
Yin	  major	  
Taiyin	  
Stage	  5=	  
Yin	  flectens	  
Jueyin	  
Stage	  6=	  
Yin	  minor	  
shaoyin	  
 
 
(Greten H. , Understand TCM Scientific Chinese Medicine- The heidelberg Model, 
2010 5th ed)	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As in hypertension ventus may be involved, more calor is generated. So as 
we can see below the pathophysiology of calor, it explains a lot regarding 
symptoms and mechanisms involved in hypertension. 
 Again(Greten H. , Understand TCM Scientific Chinese Medicine- The 
heidelberg Model, 2010 5th ed) 	  
Figure 15-Pathophysiology of Calor 
 
(Greten H. , Understand TCM Scientific Chinese Medicine- The heidelberg Model, 2010 5th ed) 
 
Again: 
BP= CO X PR         and        CO= HR X SV 
        
Therefore if calor increases the HR, stimulates the water saving 
mechanisms and increases sympathetic tone- thus increasing the peripheral 
resistance, we have here alone a good explanation for the hypertension following 
calor (induced by ventus). But we also have xue stagnation, which can be a 
consequence of qi deficiency, humor/pituita causing blockages, yin deficiency 
(leading to more uprising yang). 
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Distance Measurements in acupuncture: 
The measurements in acupuncture, as everything in Chinese medicine, are 
done taking in account the individuality of the person being treated, therefore, 
when measurement of distances on the body surface are required, it must be 
adjusted proportionally to the patient size. Thus, the individual specific standard 
of proportion is the cun. See figure below: 
 
Figure 16- Distance Measurement in Acupuncture 
 
 
	  
	  Commonly	  used	  acupoints	  for	  the	  treatment	  of	  hypertension:	  
	  
An overview of previous studies showed some of the commonly used 
acupoints for hypertension(Flachskampf, et al., 2007)(Zhang R. H., 2007)(Macklin, 
et al., 2006)(Zhou & Longhurst, Neuroendocrine mechanisms of Acupuncture in 
the Treatment of Hypertension, 2012)(Yin, et al., 2007)(Lee, Kim, Park, Kim, Lee, 
& Park, 2009) 
 
Point Name Chinese name Location 
V11 Radius magnus Dazhu 1,5 cun lateral to 
midline at the level 
of protrusion of 1st 
thoracic vertebrae 
Effects of V11: 
The “crossroads” meeting point of It, Tk, F conduit and Rg sinarteria. 
 
I Mestrado em Medicina Tradicional Chinesa 
9 
 
S-25 Cardo caeli- 2 cun lateral ao umbigo, 0.8-1 cun;  
Rs10 – Foramen pirolicum – 2 cun acima do umbigo, 0.8-1 cun profundidade – único 
ponto central. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S25 
Rs10 
1 Cun 1,5 Cun 3 Cun 
S25 
Figuras 6,7,8 – Medidas usadas para localização dos pontos de acupunctura. 
Figura 5 – Pontos S25 e Rs10. 
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Dispels ventus, cools calor. 
Master point of the bones. Influence on R orb, strengthen R orb.  
 
Point Name Chinese name Location 
V18 Inductorium 
hepaticum 
Ganshu 1,5 cun lateral to 
processus 
spinosus of the 9th 
thoracic vertebrae 
Effects of V18: 
Shu (dorsal inductory) point of the hepatic orb. 
Strengthens the hepatic and felleal orbs, refrigerating and draining humid 
calor, harmonizing the qi. 
 
Point Name Chinese name Location 
V23 Inductorium renale Shenshu 1,5 cun laterally to 
the 2nd lumbar 
vertebrae 
 
Effects of V23: 
Shu (dorsal inductory) point of the renal orb 
Strengthens and harmonizes the renal orb, nourishes the renal yin, tonifies 
the renal qi and yang 
Strengthens the loins, improves the hearing and benefits ears and eyes. 
 
Point Name Chinese 
name 
Location Neuroanathomic 
basis 
S36 Vicus tertius 
pedis 
Zusanli 3 cun below 
lower border of 
the patella, 
1cun from the 
front edge of 
the tibia, on 
the fibular side, 
at the level of 
the tibia 
tuberosity 
Subcutaneous 
nerve: 
saphenous 
nerve, peroneal 
superficial nerve 
Deep layer: 
Deep peroneal 
nerve 
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Effects of S36: 
Conjunctorium of the Stomach conduit- Earth point on Earth conduit.  
Regulates the relation between the vegetative capacity to function (QI) and 
the functional capacity bond to the body fluids (XUE)  
Eu-regulation: stabilizes the Centre (S and L orb) 
Acts in all forms of hidrostasis Humor 
 
 
 
Point Name Chinese 
name 
Location Neuroanathomic 
basis 
S40 Abundantia Fenglong Exactly 8 cun 
equidistant 
from the 
lower border 
of the patella, 
S35 and the 
prominence 
of the 
external 
malleolus 
1cun lateral 
to S38 
Subcutaneous 
nerve: 
saphenous 
nerve, superficial 
peroneal nerve 
Deep layer: deep 
peroneal nerve 
 
 
Effects of S40 
Nexorium where the link of the stomach conduit to lineal conduit 
originates 
Acts in ventus symptoms 
Transforms humor and pituita 
Calming effect, bringing down the yang (reduces function) 
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Point Name Chinese name Location 
IC4 Valles coniunctae Hegu Depression on the 
radial side of the 
index finger, distal 
to the 2nd 
metacarpophalangeal 
joint, on the border 
of red and white 
flesh 
 
Effects of IC4: 
Point f qi originale. 
Dispels ventus. 
Command point of face and mouth. 
Liberates extima. 
Promotes labor 
 
 
Point Name Chinese 
name 
Location Neuroanathomic 
basis 
IC11 Stagnum 
curvum 
Quchi Arm flexed at 
elbow -  
this point is in 
the depression 
midway 
between the 
lateral 
epicondicondyle 
of the umerus 
and the 
transverse 
crease of the 
elbow 
Subcutaneous nerve: 
ante brachial dorsal 
cutaneous nerve 
Deep Layer: 
Radial nerve trunk 
 
 
Effects of IC11: 
Conjuntorium of the crassintestinal conduit-Earth point in a Metal conduit-
promotes the yin and Orthopathy 
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Promotes the yin of the conduit, which is responsible for the rhythm and 
enteral coordination e acts in metal phase (relaxation), eu regulation to metal 
phase 
Dispels ventus-relaxing action on sympathetic system 
Cools calor balancing the building energy and xue 
 
Point Name Chinese 
name 
Location Neuroanathomic 
basis 
F20 Stagnum 
venti 
Fengchi  Depression between 
the 
sternocleidomastoid 
and trapezius 
muscles, at the 
same level as Rg 16 
Depression between 
the 
sternocleidomastoid 
and trapezius  
muscles 
 
Effects of F20: 
Meeting point with the Tk conduit, yang wei mai, yang qiao mai (active in 
uprising yang) 
As the name says ‘pool of wind’, means point where the disturbance of 
flow is localized.  
Major point of ventus disorders- Dispels ventus 
 
Point Name Chinese name Location 
F34 Fons tumuli yang Yanglingquan Depression 
anterior to the 
head of the fibula 
 
Effects of f34: 
Conjunctorium of the felleal conduit. Earth point on a wood conduit. 
Strengthen the qi in the middle and lower caloric, thus stabilizing and 
regulating the lineal and renal orb, but also the hepatic and the felleal orb- 
benefiting the tendon and joints, eliminating humor, ventus and calor 
heteropathies. 
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Point Name Chinese 
name 
Location Neuroanathomic 
basis 
F39 Campana 
suspensa 
Xuan zhong 3 cun above 
external 
malleolus 
Anterior border 
of the fibula 
 
Effects of F39: 
Connects all three yang channels of the foot (felleal, Vesical and Stomach) 
Powerfully deploys qi in middle and upper caloric, thus dispels ventus, 
control the yang, transforms pituita, draining humor. 
Promotes the smooth flow of hepatic and felleal qi. 
Master of the marrow. 
 
 
Point Name Chinese 
name 
Location Neuroanathomic 
basis 
L4 Basis 
metatarsalis 
Gongsun 1 cun 
proximal to to 
L3, in a 
depression, 
distal to the 
basis of 1st 
metatarsal, on 
the border of 
the red and 
white flesh 
Subcutaneous 
nerve: 
saphenous 
nerve, superficial 
peroneal nerve  
Deep layer: 
medial plantar 
nerve 
Effects of L4: 
Nexorium linking Stomach and Lienal conduits. Strengthens the Stomach 
and Lienal Orb 
Opens the synarteria Impedimentalis 
Corrects repletion caused by humor 
Regulates qi and transforms excessive humor 
Calms shen 
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Point Name Chinese 
name 
Location Neuroanathomic 
basis 
L6 Copulatio 
trium yin 
Sanyinjiao 3cun 
vertically 
above the 
medial 
malleolus, at 
the posterior 
margin of the 
tibia 
Subcutaneous 
nerve: 
saphenous nerve 
Deep layer: tibial 
nerve 
 
 
Effects of L6: 
Connects all 3 yin conduits of the leg (Lienal, Renal and Hepatic). 
Strengthens the Lienal orb, improving the metabolism. 
Relaxes the hepatic orb and stabilizes the Renal orb, makes more dynamic 
and enhance fluids circulation. Master of the lower caloric. 
 
 
Point Name Chinese name Location 
L9 Fons tumuli yin yinlingquan With the knee 
flexed, it is in a 
depression at the 
lower border of 
the medial 
condyle. 
 
Effects of L9: 
Conjunctory of the lineal conduit. Water point on an earth conduit. 
Regulates the lineal orb, transforms humor. 
Local point for the knees. 
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Point Name Chinese name Location 
H2 Intertitium 
ambulatorium 
Xingjian Between 1st and 2nd 
toe, distal to the 
terminal phalanx of 
the big toe 
 
Effects of H2: 
Effusory of the hepatic conduit (Fire point on a wood conduit) 
Stabilizes and harmonizes the hepatic orb. 
Cools calor.  
 
Point Name Chinese 
name 
Location Neuroanathomic 
basis 
H3 Impedimentale 
major 
Taichong Between the 
metatarsals of 
the 1st and 2nd 
toe, in a 
depression 
about 1,5 cun 
proximal to 
the terminal 
phalanx of 
the big toe 
Subcutaneous 
nerve: nerve 
saphenous 
superficial 
 
          Effects of H3: 
Proven action in conventional medicine: increases the plasmatic level of 
endothelin, ameliorates hypertension 
In TCM: Inductorium of the hepatic conduit-Earth point (orthopathy) on a 
wood conduit-potential, i.e. brings eu-regulation to the potential 
Point of hepatic qi originale 
Stabilizes and regulates hepatic and felleal orb, regulating and reducing 
the excess activity of Xue 
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Point Name Chinese 
name 
Location Neuroanathomic 
basis 
Pc5 Foramen 
intermedium 
Jianshi 3cun 
proximal to 
the transverse 
crease of the 
wrist, 
between 
tendons of 
the Palmaris 
longus and 
the flexor 
carpi radialis 
 
 
Deep layer: deep 
median nerve 
Effects of Pc5: 
Transitory of the Pc conduit. Metal point on fire conduit. 
Calms the shen and cardial orb. 
Stabilizes and regulates the C and Pc orbs, calming ventus, checking calor 
Directs qi down to the middle caloric 
Transform pituita and harmonize the S orb. 
 
 
Point Name Chinese 
name 
Location Neuroanathomic 
basis 
Pc6 Clusa interna Neiguan 2cun 
proximal to 
the transverse 
crease of the 
wrist, 
between 
tendons of 
the Palmaris 
longus and 
the flexor 
carpi radialis 
 
 
Deep layer: deep 
median nerve 
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Effects of Pc6: 
Nexory of pericardial conduit 
Opens the synarteria retinens yin 
Stabilizes and harmonizes the cardial and lineal orb, regulation qi, draining 
and dispersing Yang and ventus, calor and humor 
 
 
Point Name Chinese 
name 
Location Neuroanathomic 
basis 
C7 Porta shen 
 
 
 
 
 
 
 
 
 
 
Shenmen Proximal and 
radial to 
pisiform bone 
in the 
transverse 
crease of the 
wrist, radial 
to the flexor 
carpi ulnaris 
 
Subcutaneous 
nerve: radial 
cutaneous nerve 
Deep layer: ulnar 
nerve trunk 
 
 
Effects of C7: 
Inductorium of cardial conduit: 3rd antique point 
Earth point (eu-regulation)of the cardiac conduit 
Stabilizes the cardial orb (which transforms potential into function 
Re-establishes the functional capacity of the sinarterias e regulates the 
yang excess function) 
 
Point Name Chinese name Location 
R3 Rivulus maior Taixi Midway between 
the medial 
malleolus and the 
Achilles tendon 
(palpable pulse) 
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Effects of R3: 
Indutorium of the renal conduit (qi original point) Earth point on a water 
conduit. 
Stabilizes and regulates the renal and hepatic qi.  Cools calor 
 
Point Name Chinese 
name 
Location Neuroanathomic 
basis 
R7 Amnis 
recurrens 
Fuliu In a 
depression at 
the anterior 
margin of the 
Achilles 
tendon, 2 cun 
above R3 
Subcutaneous 
nerve:saphenous 
nerve, sural 
medial 
cutaneous nerve 
Deep layer: tibial 
nerve 
 
Effects of R7: 
It’s is the point for the fluids, regulate the corporal fluids e promotes renal 
yin (promotes the regeneration) 
It is the transitory of the renal conduit-metal point on a water conduit-
stimulates the distribution of the vegetative capacity to function (qi)on the 
conduit, with protective effects. 
Stabilizes and regulates the fluid metabolism, controlling specially the 
calor-humidity 
 
Point Name Chinese 
name 
Location Neuroanathomic 
basis 
Rg 14 Omnium 
defatigatorum 
Dazhui Depression 
below the 7th 
cervical 
vertebra 
Below 7th cervical 
vertebra 
Effects of Rg 14: 
“Foramen of all stress and strain” 
Stabilizes and regulates the qi of the centre , thus transforming calor 
humidus. 
Dispels ventus, cools calor 
Calms shen and ventus internus 
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Strengthens the qi and yang in deficiency conditions 
Strengthens the hepatic and pulmonary orb 
 
 
Point Name Chinese 
name 
Location Neuroanathomic 
basis 
Rg 20 Conventus 
omnium 
Baihui In the centre 
of the top of 
the skull, 
aprox. 7cun 
from the 
posterior and 
5 cun from 
the anterior 
hairline. 
At the junction 
of a line 
connecting the 
apices of the 
ears and the 
midline. 
 
Effects of Rg 20: 
Meeting point of yang conduits (F, V, Tk) and hepatic conduit. 
Calm ventus, pacify yang, calms the shen. 
Stabilizes and regulates the hepatic orb. 
 
 
Point Name Chinese name Location 
Rs 4 Prima clusarum Guanyuan 3 cun below the 
navel 
Effects of Rs4: 
Mu point of tenuintestinal Insertion poit of the Rs,hepatic and lineal 
conduits 
Stabilize the renal orb, consolidating the original qi 
Controls and directs the yang downwards. 
 
Point Name Chinese name Location 
Rs 6 Mare qi Qihai 1,5 cun below the 
navel 
Effects of Rs6: 
Tonifies the qi. 
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Stabilizes and regulates the renal orb. 
Directs the yang downwards. 
 
Point Name Chinese name Location 
Rs 12 Conquisitorium 
stomachi 
Zhongwan  4cun above the 
navel and 4 cun 
below xiphoid 
process 
 
Effects of Rs 12: 
Mu point of stomach. 
Point of reunion of the functions of all yang orbs. 
Regulates the stomach orb, harmonizing its qi, -thus strengthening the 
centre, draining humor 
 
 
Point Name Chinese name Location 
Ex-HN-5 Taiyang Taiyang Depression in 
1cun lateral to the 
mid point of a line 
connecting the 
lateral extremity 
of the eyebrow 
and the outer 
canthus of the 
eye. 
 
Effects of the taiyang: 
Dispels ventus,Cools calor. 
Transforms humor. 
 
(Greten H. , Understand TCM Scientific Chinese Medicine- The heidelberg 
Model, 2010 5th ed),(Zhang R. H., 2007)(Jin, 2006; Kaptchuk, 2002)(Porkert M. a., 
1995)(Hempen, 2006)(Zhou & Longhurst, Neuroendocrine mechanisms of 
Acupuncture in the Treatment of Hypertension, 2012)(Stéphan, 2010)(Xia)(Focks, 
2008)(Deadman, Al-Khafaji, & Baker, 1998)(Ferner & Staubesand, 1984) 
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II. CLINICAL RESEARCH PROTOCOL 
Title: Effect of Acupuncture as a complementary therapy in the treatment of 
patients with Essential Systemic Hypertension 
 
1.Background:  
Hypertension prevalence worldwide is estimated to be almost 1 billion 
individuals and it can be related to as much as 7million deaths per year. 
Moreover, it is the first cause of death worldwide. It is estimated that in Portugal 
about 42% of the adult population aged 18-90 years has hypertension. That 
number corresponds to approximately 3 million people. Among those patients 
only 36% are aware of their high blood pressure and only about 11% are treated 
adequately. The prevalence of hypertension increases with the age of the people, 
reaching about 78% in older than 64 years.(Macedo, Lima, Silva, Alcantara, 
Ramalhinho, & Carmona, 2005) 
In the first year of therapy only 60% of the patients will continue the 
medication (Caro, Speckman, Raggio, & Jackson, 1999)(Massaglia, et al., 
2005)and after 5-10 years as much as 60% will abandon their prescription for 
hypertension(Caro, Speckman, Raggio, & Jackson, 1999; Chao, Shen, Tjen-A-Looi, 
Pitsillides, Li, & Longhurst, 1999). 
The use of acupuncture could help overcome these difficulties, by either 
diminishing or substituting the amount of drug required, and also because with 
frequent visits to the clinic it eases the compliance to the treatment (drugs 
and/or adjustment of lifestyle).  
 
2. Research team 
 2.1 Main investigator: 
  2.1.1 Deise Noriko Matsui Nishimura 
• Physician graduated from  Faculdade de Medicina da 
Universidade de São Paulo (USP) – Brazil, and degree 
recognized by Faculdade de Ciências Médicas da 
Universidade Nova de Lisboa 
• Specialized in Cardiology (3 years of internship) at 
Instituto do Coração (INCOR)- do Hospital das Clínicas 
da FMUSP 
• Master student of Traditional Chinese Medicine at the 
Instituto de Ciências Biomédicas Abel Salazar (ICBAS) 
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2.2. Research supervisors 
 2.2.1 Main supervisor: 
 Prof. Dr. Henry Johannes Greten 
• Head of the Heidelberg School of Traditional 
Chinese Medicine 
• President of the German Society of Traditional 
Chinese Medicine (DGTCM), Heidelberg-
Germany 
• Associated professor at ICBAS-Universidade do 
Porto 
2.2.2 Co-supervisors: 
Prof. Dr. Jorge Machado 
• Associated professor at ICBAS- Universidade do 
Porto (UP) 
Dr. Nuno Cândido Maia Correia 
• Assistant physician at Hospital de São João- 
Porto 
• Master in TCM from ICBAS-UP 
 
3.Objectives:  
 
3.1 General objective: To study the acute effect of acupuncture in patients 
with mild to moderate essential hypertension (EHT).  We search for answers to the 
following questions: 
1. Is there an acute effect of the treatment of hypertension? 
 We plan to answer this question by measuring the BP before and 
 after each treatment. 
2. Can we consider that “ white coat” hypertension is playing a role in 
the results? 
 In order to avoid this effect we will use the comparison between the 
 24-ABPM before and after the course of 3 treatments. 
3. Does acupuncture have an effect in the average systolic, average 
diastolic or both? 
 We will compare the average systolic and diastolic separately.  
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4. Is there any period during the day in which acupuncture exerts 
preferentially its effects? 
 We will compare the average systolic and diastolic blood pressures 
 during daytime with night-time. 
5. Does acupuncture have an effect in long term prognosis for 
cardiovascular events? 
We will assess the BP variability-(standard deviation	   around mean	  
values).The variability of blood pressure may have a prognostic 
value in hypertension patients. (Mancia, et al., 2007)(Mancia, 
Prognostic value of long-term blood pressure variability:the 
evidence is growing, 2011) 
 
 4. Methods: 
 4.1 Setting: 
The study will be performed in an outpatient clinic, in Brejos do Azeitão, 
Portugal. 
 
4.2. Study population: 
Patients from general population, younger than 70 years old, recruited via  
local newspaper, leaflets in clinics, with essential mild to moderate 
hypertension. 
 
4.2.1 Inclusion Criteria: 
• Patients with essential hypertension high normal, grade 1 , 
grade 2 according to ESH/ESC guidelines 2007 i.e. Systolic Blood 
Pressure (SBP) <180mmHg or Diastolic Blood Pressure (DBP) 
<110mmHg 
• Age < 70 years old 
• No change in antihypertensive medications in the last 60 
days 
• Patient must sign a written informed consent. 
• Patients naïve to acupuncture 
 
4.2.2   Exclusion criteria: 
• Secondary causes of HT  
• History of white coat hypertension 
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• History of stroke, coronary heart disease 
• History of heart failure 
• Poor compliance to the study 
• Bleeding disorder 
• Needle panic/fear 
• Neurologic diseases affecting motor, sensorial pathways 
• Mental /cognitive diseases 
• Endocrinopathy (hyper/hypothyroidism, acromegaly, 
Cushing…) 
 
          4.3 Study design 
This study will be triple  (patient, interventionist, data collector) blinded, 
randomized, controlled, prospective, pilot clinical trial. 
The patients will come for 5 days during a week, from Monday to Friday 
(Figure	  18) 
 
4.3.1. Blinding  
Blinding will be done based on the model already applied in a Heidelberg  
group’s study, as follows:(Hauer K, 2011) 
 
 
Figure 17- Blinding in the study protocol 
 
Hauer K, Wendt I, Schwenk M, Rohr C, Oster P, Greten HJ, Arch Phys Med Rehabil 2011 Jan; 
92(1): 7-14 (with permission) 
Author's personal copy
or the nonacupoint, respectively. The depth of skin penetration
was 0.5 cm and limited by the shape of the needles. This type
of technique is also known as the leopard spot technique and
belongs to the “5 kinds of punctures” as named in the classic
textbook Ling Shu and is recommended for the “numbness of
muscles.”40
Intervention
For verum treatment, the acupuncture point stomach 34
( , liáng-qiu!-xué, monticulus septi) was used, located 2
cun proximal the superior lateral border of the patella. This
acupoint was chosen according to the theory of Chinese Med-
icine as described by the Heidelberg Model of TCM.41 This
point, besides its analgetic effect, has traditionally been used
for weakness of the legs and neurologic deficits in the lower
extremities as induced by palsy or hemiplegia. Control treat-
ment was performed at a nonspecific skin point with no direct
relation to any conduit (meridian) between the felleal conduit
(gallbladder meridian) and the lateral posterior border of the
femur and at the same height as the verum point (fig 2).
The sample size was calculated for the increase of maximum
gait speed after acupuncture using results of a pilot study
(unpublished data, Hauer 2008) based on a statistical power of
80% and a significance level of 0.05 to verify a significant
intervention effect.
Statistical Analysis
Statistical procedures were performed on SPSS 17.0 for
Windowsc by an intention-to-treat analysis. Exploratory anal-
ysis determined the variability and distribution of outcome
variables. Unpaired t tests, Mann-Whitney U tests, and chi-
square tests were used for baseline comparison as appropriate.
Effects of intervention between group were analyzed by 2-way
analysis of variance for repeated measures (group ! time). A
2-sided P value !0.05 indicated statistical significance. Effect
sizes for change within groups were calculated as mean
changes between groups divided by pooled standard deviation
at baseline.42 Effect sizes represent a method for reporting the
magnitude of change without unit of measurement.43 Data are
presented as means (standard deviation) or medians (range).
RESULTS
Recruitment
Sixty older patients were consecutively recruited between
November 2008 and July 2009 and tested within the last 2 days
of their 3-week geriatric ward rehabilitation (fig 3). Study
participants represented a sample of multimorbid, older per-
Fig 1. Illustration of test proceeding and blinding: multiple blinding according to a 5-step test procedure.
Fig 2. Location of acupoint ST-34 and the nonacupoint used for
control treatment.
9EFFECT OF ACUPUNCTURE ON GAIT, Hauer
Arch Phys Med Rehabil Vol 92, January 2011
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- In step 1 (blinding of the patient), a trained acupuncturist will mark in 2 
different colours the “real” acupoints and the sham point. The sham 
points will be the control patients. 
-  In step 2 (blinded assessor, baseline measurement), the type of 
intervention will be invisible to the BP pressure taking person and to the 
24-ABPM analyser, resulting in blinding of the test assessors. 
- In step 3 randomization to 1 of the 2 study groups  
- In step 4 (blinding of the acupuncturist), a person not trained in TCM, but 
supervised will perform the treatment using the points marked with the 
respective colour according to the randomization code. 
-  In step 5 (post-acupuncture measurement), effects of the acupuncture 
will be assessed with a BP measurement analysis and after the 3 days- 
protocol a new 24 ABPM will be taken.  
 
This blinding of the interventionist will take place only on the first day due 
to technical reasons (many points utilized in the intervention, with different 
techniques of stimulations). Data (HR/BP) from the first day of treatment will 
be compared to the baseline to check for super acute effects with triple 
blinded treatment. 
The patient and assessors blinding will continue on the following days. 
The blinding of the patients is important because their beliefs and/or 
expectations regarding the therapy can influence the response.(Kaptchuk, 
2002)(Flaten, Simonsen, & Olsen, 1999). Because this protocol has a short 
interval we believe that the possibility to keep the masking will be effective- 
no “guessing” by the patient regarding which group he/she is, either 
according to the BP levels observed or by talking to each other about the 
colours of the points.  
 
4.3.2. Randomization 
Drawing an envelope among a pool of envelope containing different colours 
will randomize subjects into 2 groups: real or sham acupuncture. 
 
4.3.3. Control 
Control will be done in an invasive control regimen, using acupoints outside 
the conduits, based on a previous publication in Circulation(Flachskampf, et 
al., 2007), plus points without known autonomic effects or with no effects 
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on experimental hypertension (Zhou & Longhurst, Neuroendocrine 
mechanisms of Acupuncture in the Treatment of Hypertension, 2012), or 
without indication to hypertension according to TCM 
 
4.3.4 Experimental protocol 
 4.3.4.1. Monday-Day 0 “Baseline” or pre-intervention phase 
The study personnel will explain to the subjects details about the 
study, the number of days required, the acupuncture treatment 
(penetrating, thin needles) and possible but minimal risks of acupuncture 
treatment (hematoma, infection, fainting etc.). The signature of the written 
consent (see appendix 2) will be obtained, BP/HR measured and the 
installation of the 24-ABPM will be done.  
 4.3.4.2 Tuesday –Randomization and triple blinded study 
The patients will come to the clinic to take out the 24-ABPM  and 
then will get the points marked in 2 different colours by an acupuncturist. 
Then the BP and HR will be measured according to ESH/ESC guidelines. 
After this procedure, they will draw the envelope containing the colour of 
the group assigned and will proceed to the supervised nurse, who will 
puncture the points marked with the same colour contained inside the 
envelope. (The patient must not show the colour to any other person). 
After 30min of the treatment a person other than the nurse who applied 
the puncture will assess the BP and HR again. 
4.3.4.3 Wednesday and Thursday 
 Patients will return to the clinic and have their BP and HR checked 
before and after 30 min of the intervention. In these days a certified 
acupuncturist will do the intervention (who will now be allowed to see the 
colour group the patient is, but the remaining personnel shouldn’t know 
the colour until the end of the study protocol). After the intervention on 
Thursday the 24-ABPM will be installed again. 
4.3.4.4 Friday 
 Take off the monitor. BP and HR checked. Data will be analysed by a 
third person unaware of the protocol. 
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Figure 18 - STUDY DESIGN 
 
 
Part	  I	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Part	  II	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Group 2                 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Group	  1	  
Part	  III	  	  Monday	  	  	  Tuesday*	  	  	  	  Wednesday	  	  	  	  	  Thursday	  	  	  	  	  	  	  	  	  	  
Friday 
 
 
• Treatment on Tuesday will be done by blinded acupuncturist (see above) 
Group 1 = ‘real acupuncture” Group 2 =sham acupuncture (control)  
 
Part	  IV:	  	  Data	  analysis	  (independent	  analyser):	  average	  systolic	  and	  diastolic	  BP,	  
analysis of the average day-time and night time systolic and diastolic BP  
BP variability analysis 
   
Patient Screening:adds on local  
newspapers, flyers in clinics...	  Patient	  selection	  (inclusion/exclusion	  criteria)	  
                 Randomization   
     Health data/lifestyle Questionaire 
       Signature of written consent  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  24-­‐ABPM	   	  24-­‐ABPM	  	  
BP/HR	  check	  	  	  	  T1	  Points*	  BP/HR	  check	  	  
BP/HR	  check	  T1	  Points	  BP/HR	  check	  24-­‐ABPM	  	  
24-­‐ABPM	  taken	  out	  BP/HR	  check	  
BP/HR	  check	  T2	  Points*	  BP/HR	  check	  
BP/HR	  check	  T1	  Points	  BP/HR	  check	  24-­‐ABPM	  
24-­‐ABPM	  taken	  out	  BP/HR	  check	  	  
BP/HR	  check	  T1	  Points	  BP/HR	  check	   BP/HR	  check	  T2	  Points	  BP/HR	  check	  
	   81	  
 
4.4 Intervention: 
Acupuncture 3 sessions (1session/day) on Tuesday, Wednesday and 
Thursday . 
BP and HR measurement before and after the acupuncture sessions 
BP to be measured according to ESH/ESC recommendations- see above 
24-ABPM before and after the treatment period  
Acupuncture treatments: 
 Group 1: “real” acupuncture- based on a concept of acupuncture 
according to Heidelberg Model of Chinese Medicine, aiming close 
to the principle of ALT and suitable for yin deficiency and uprising 
yang 
- F39 –Felleal (Gall Bladder)39: campana suspensa/Xuan zhong 
-  Rg14- Regens (GV)14: Omnium defatigatorum/ Dazhui 
-  Pc 6-  Clusa interna/ Neiguan  
-  F20- Felleal (Gallbladder) 20: Stagnum venti/Fengchi 
-  Rs12- Respondens 12:conquisitorium stomachii/Zhongwan 
-  L6- Lienal (Spleen) 6: Copulatio trium yin/Shangqiu 
-  R7: Renal (kidney) 7: Amnis recurrens/Fuliu 
 
 Group 2: sham-acupuncture- an invasive control using acupoints 
outside the conduits, based on a previous publication in 
Circulation(Flachskampf, et al., 2007), plus points located outside 
the conduits between points without known autonomic effects or 
with no effects on experimental hypertension (Zhou & Longhurst, 
Neuroendocrine mechanisms of Acupuncture in the Treatment of 
Hypertension, 2012) 
 
Both treatments will be performed using the same number of 
needles, applied bilaterally (except Rg14 and Rs12, because they 
are in the midline), needles will be left for 30 minutes, in a calm 
and tranquil treatment room in the clinic. 
Stainless steel sterile, single use needles with ø=0,25mm and 
length of 25mm will be used in both groups. 
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4.5 Main parameters: 
  
Blood pressure measurements: 
 Should be done as the ESH/ESC recommendations(ESH/ESC, 2007): 
• Patients should rest for several minutes in a quiet room 
before measurement 
• At least 2 measurement with interval of 1-2 minutes, and 
more if those 2 are very different  
• The bladder should be adequate to the arm size 
• Keep the cuff ate heart level 
• Use phase I of Korotkoff sound for systolic BP and phase V 
(disappearance) for the diastolic BP 
• Measure the BP at both arms to detect possible difference as 
a consequence of peripheral arterial disease. Use the higher 
value as a reference value 
• Measure BP 1 and 5 min after orthostatic position in elderly, 
diabetics and other conditions necessary to verify postural 
hypotension 
• Measure the heart rate after the second measurement in the 
sitting position (pulse palpation for at least 30 seconds). 
 
24h-ABPM 
The 24h ABPM was chosen as an assessment tool because it has 
some advantages over the office only measure: 
• Provides the average blood pressure, as well as a mean 
values over a period of time (day, night, morning) 
• Reflects the variation of BP during daily life, not only during 
office visits 
• Absent or negligible “white coat” or placebo effect(Staessen, 
et al., 1994)(Mancia, Omboni, Parati, Ravogli, Vilani, & 
Zanchetti, Lack of placebo effect on ambulatory blood 
pressure, 1995) 
• Better prognostic value 
• Gives information about BP variability (standard deviation 
around mean values) 
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• And very importantly for a study protocol- it has a higher 
reproducibility over time(Coats, Radaelli, Clark, Conway, & 
Sleight, 1992)(Mancia, Ulian, Parati, & Trazzi, 1994) 
 
  Data to be analysed: 
 
1. 24 hour-Ambulatory blood pressure monitor (ABPM)- average 
systolic and diastolic BP- before and after the treatment regimen 
2. Regular blood pressure BP/HR checking before and after each 
session. 
3. Analysis of the average day-time and night time systolic BP and 
diastolic BP –before and after treatment regimen 
4. Analysis of the BP variability and by analysing this parameter we 
could assess indirectly the effect of acupuncture also in the 
evolution of worsening hypertension target organ lesion and 
incidence of cardiovascular events.(Mancia, Prognostic value of 
long-term blood pressure variability:the evidence is growing, 
2011)(Mancia, Omboni, Ravogli, Parati, & Zanchetti, 1995) 
 
 
5. Study steps plan: 
 
1st step- ICBAS ethics committee approval 
2nd step- publishing in local newspaper, flyers in local health care out patient 
clinics 
3rdstep- patient selection 
4th step- study protocol 
5th step- Publication 
 
6. Research partnership: 
 ICBAS TCM Master Programme. 
 
7. Ethical considerations: 
This research protocol has been submitted to the Ethics Committee (EC) of 
ICBAS for approval. (Appendix 1) 
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The study is to be conducted according to the 1964 Helsinki Declaration 
and international standards of Good Clinical Practice requirements.(ICHS, 
1997)(Medical Research Council , 1998)  
All subjects for this study will receive a consent form describing the 
protocol and offering sufficient information for them to make an informed 
decision about their participation in this study. Subjects are informed about the 
goals, methods, expected benefits, and potential risks or discomforts, and have 
the right to decide to withdraw or continue at any moment during his/her 
participation; subject is also aware that no prejudice will result if him/her refuses 
to participate or withdraws from the study. (Appendix2) 
This informed consent is to be obtained from all participants before 
randomization and is considered an inclusion criteria. This consent form is to be 
approved by the ethic committee and must be signed by the subject or legally 
acceptable surrogate and the research professional obtaining the consent.  
Multiple studies have shown that the incidence of adverse effects of 
acupuncture is low. (Melchart, et al., 2004)(Witt, 2011)(Ernst, Strzyz, & 
Hagmeister, 2003)(Norheim, 1996)  
Subjects will be asked about adverse experiences at each visit, defined as 
any unfavourable and unintended sign, symptom or disease temporally 
associated with the use of the acupuncture treatments.  
The trial will be stopped if the investigators believe there is an 
unacceptable risk of serious adverse events in one of the treatment arms.  
 
8. Results:  
  This proposed clinical protocol has been submitted for approval by the 
Ethics Committee of ICBAS (appendix 1), the authorization to work on the clinic 
has been granted (appendix 3), and steps towards its completion are being 
accomplished. 
 Results of this trial may provide data regarding acute effects of 
acupuncture for hypertension that could be useful for researches with larger 
population, longer follow up periods. 
 Since there is no data yet available at the time of this thesis submission, 
we can only comment on the study hypothesis. 
 The 2 groups should be with no statistically significant differences 
regarding age, gender, use of medication 
	   85	  
 It is expected that the real acupuncture could show decrease in blood 
pressure even after one treatment and this effect could be assessed with the BP 
measurement before and after each session. 
 It is foreseen that the real acupuncture could demonstrate a significant 
reduction both in the mean systolic and mean diastolic BP during the 24-ABPM, 
compared to the sham group. 
 Also it is anticipated that the variability of the BP will increase significantly 
more in the real acupuncture group, thus giving the indication that it can also 
reduce the cardiovascular events in the future. 
 
9. Discussion 
 This study may reveal a significant decrease in both systolic and diastolic 
blood pressure, compared to the sham group because acupuncture exerts 
sympatholytic, pro-vagotonic, anti-inflammatory and also action on the renin, 
angiotensin aldosterone system, according to recent literature. Also it was 
discovered a specific neurological pathway participating in acupuncture inhibition 
of excitatory cardiovascular reflexes: a long loop pathway for cardiovascular 
modulation, involving the arcuate nucleus of the hypothalamus, ventrolateral 
periarqueductal gray, the rostral ventrolateral medulla cardiovascular centre and 
the nucleus raphé through direct or indirect actions, apparently acting acts 
through opioids (endorphins, enkephalins, perhaps endomorphin, but not 
dynorphin) serotonin, GABA. These entire systems have effects on the 
pathophysiology of the hypertension.  
 By analysing the 24-ABPM data we could get more accurate, reproducible 
measurement of the extent of the reduction induced by the treatment, in 
addition, it can provide information regarding to in which part of the 24 hours 
(day or night) the results were more pronounced.  
Because it is a short time study, action of external factors such as change 
in medicaments, change of lifestyle, diet, alcohol intake, smoking status are less 
likely to happen and influence results. 
This protocol results will provide data to grant a larger prospective, 
controlled, multi-blinded, randomized protocols, with longer follow up periods. 
Limitations: 
When a nurse with no knowledge of TCM applies the treatment she/he will 
not be able to orient the patient to ‘de-qi’, there will be no needle stimulation, 
which in some cases can diminish the effect of the acupuncture. There are some 
	   86	  
points that require a specific kind of stimulation and this cannot be done without 
some knowledge of TCM. The following days an acupuncturist will perform the 
treatment.  
The blinding of the interventionist will be made only on the first day due to 
technical reasons – a large number of points (12 in total) for a non-experienced 
nurse to apply.  But there are reports that the utilization of some points alone can 
produce effects in lowering the blood pressure, such as F39.(Wei, 2006), so we 
could expect some results even on the first day. And the number of points will be 
limited to the same number of points as the sham treatment (in order to keep the 
blinding of the patient). 
Although in this study we will utilize acupoints selected by a very well 
experienced Chinese and western medicine doctor, we will use the same points 
for a western diagnosis of hypertension, not necessarily the same Chinese 
diagnosis.  
In this study we will include patients taking their medication, however, 
because this protocol is short, changes that could be attributable to change in 
medication are easier to avoid 
The analysis of the BP variability can indirectly provide information 
regarding prognosis of a cardiac event(Mancia, Prognostic value of long-term 
blood pressure variability:the evidence is growing, 2011), this study will show it 
only over a short period of action of the acupuncture, longer treatment plan and 
follow up are necessary to confirm this information. 
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10. Future perspectives: 
 Acupuncture and TCM have existed for thousands of years and the interest 
in its utilization has been increasing in western world. 
 Although limitations exist regarding the study design, proper blinding, 
choosing the correct control group such as cross over design, ideal sham 
treatment (acupoints/nonacupoints, non penetrating needles), scientific 
evidences towards its usefulness is growing. And there have been more and more 
well designed, randomized studies with Chinese medicine/acupuncture also in 
the western society. 
 As for acupuncture to treat cardiovascular diseases, despite many research 
involving animals and humans, only a part of its mechanisms is known. Promising 
results from well-designed clinical trials suggests that it has clinical value. But 
there are yet a lot of unanswered questions, some of them are addressed below: 
1. Is there a specific hypertension patient group in which the acupuncture 
is more indicated? 
2. Is the acupuncture efficient to substitute medicaments?  
 More studies are required to check the effects of acupuncture as a 
‘substitute’ for the drugs prescribed, or if it is an important tool but 
only as a complementary therapy.  
In order to answer these questions above it would be necessary but 
difficult to study patients with higher grades of Hypertension and take 
out their medication due to ethical reasons. 
3. Is the treatment according to Chinese diagnosis superior to standard 
pre determined points? 
4. Is there a specific Chinese diagnosis group in which the effect is more 
pronounced? 
It makes sense to make a study design with experienced Chinese 
medicine doctors making Chinese diagnosis and treating using 
individualized treatments to check the effects when applying Chinese 
diagnosis individually. There were, indeed, some good studies using 
Chinese diagnosis, (Flachskampf, et al., 2007)(Yin, et al., 
2007)(Macklin, et al., 2006), but they didn’t mention the diagnosis 
made, and hadn’t separated the groups according to their Chinese 
diagnosis, so it wasn’t possible to know if a specific type of 
hypertension according to Chinese diagnosis were more “treatable” 
with acupuncture than the others. 
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A large study dividing and describing the groups according to their 
Chinese diagnosis would allow better correlation between western and 
Chinese diagnosis thus making possible to identify the groups and 
results. 
 
5.  Which is the ideal duration/interval for treatment? 
6.  Is there any residual effect and if so, how long does it last? 
Studies with longer period of treatment and follow up are required to 
answer these questions. 
5. Is electro acupuncture superior to manual acupuncture in the treatment 
of hypertension? 
The direct comparison with proper blinding between manual 
acupuncture and electro acupuncture is difficult. Although there are 
some studies in animals, it is hard to blind the patient to these 
different techniques as the stimulus of the electro acupuncture can 
easily be identified. One option could be cross over studies, where each 
subject would go through all the 3 treatments, but even so an 
expectation of the result could influence the results. In addition, more 
data would be necessary to proper define the wash out period.  
 
6. Can the acupuncture influence the prognosis of hypertension by 
reducing the cardiovascular events (stroke, coronary heart disease, and 
heart failure? 
Large, randomized, prospective, controlled, blinded with longer follow 
up not only to assess this effect indirectly by reducing the BP levels, but 
proper long follow up are important to check the real direct impact of 
acupuncture in these outcomes.   
 
   Furthermore, there are other tools in TCM that could be useful in treating 
hypertension and other cardiovascular diseases such as Qi Gong, phytotherapy 
that could also be explored and studied systematically. 
 Beside the difficulties, efforts towards the integration between the western 
and eastern medicine are worthy as it would greatly contribute to reach the 
ultimate goal that is to control this awful disease responsible for a great number 
of disabilities and deaths worldwide. 
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